Tumor
General Information
1. True or False. The following tumor is considered to be a World Health Organization (WHO) grade IV: |
| G7 p.582:97mm |
a. anaplastic astrocytoma | false (Anaplastic astrocytoma is a grade III.) | G7 p.582:117mm |
b. gliosarcoma | true | G7 p.582:12mm |
c. fibrillary astrocytoma | false (Fibrillary astrocytoma is a grade II.) |
|
d. subependymal giant cell astrocytoma | false (Subependymal giant cell astrocytoma is a grade II.) | G7 p.582:148mm |
2. True or False. Tumors of mixed neuronal-glial origin include the following: |
| G7 p.583:45mm |
a. ganglioglioma | true |
|
b. central neurocytoma | true |
|
c. primitive neuroectodermal tumor (PNET) | false (Primitive neuroectodermal tumor [PNET] is listed under embryonal tumors. Old nomenclature is medulloblastoma—small round blue cell tumor.) |
|
d. desmoplastic infantile ganglioglioma (DIG) | true |
|
3. Complete the following about general tumor information: |
| G7 p.583:95mm |
a. Medulloblastoma is considered to be what type of tumor? | embryonal |
|
b. It is also known as_____. | PNET |
|
4. What are the two types of craniopharyngioma? |
| G7 p.584:180mm |
a. a_____ | adamantinomatous (“Adam Antinomatous”) |
|
b. p_____ | papillary | |
5. List the four most common presentations of brain tumor and their frequency. |
| G7 p.585:160mm |
a. p_____ n_____ d_____— _____% | progressive neurologic deficit—68% |
|
b. h_____—_____% | headache—54% |
|
c. m_____ w_____—_____% | motor weakness—45% |
|
d. s_____—_____% | seizure—26% |
|
6. When encountering a first-time seizure in a patient older than 20 years of age, think_____until proven otherwise. | tumor | G7 p.586:38mm |
Infratentorial Tumors
7. What is the name of the so-called vomiting center? | area postrema | G7 p.586:145mm |
8. What nerve has the longest intracranial course? | sixth nerve (abducens) | G7 p.586:160mm |
9. Matching. Match the area of cerebellum with symptoms. |
| G7 p.586:165mm |
Area of cerebellum: |
|
|
|
|
|
a. Ataxia of extremities |
| |
b. Broad-based gait |
| |
c. Truncal ataxia |
| |
d. Dysmetria |
| |
e. Intention tremor |
| |
f. Nystagmus |
| |
g. Cranial nerve dysfunction |
| |
10. Complete the following concerning a > 20-year-old patient presenting with a headache: |
| G7 p.587:120mm |
a. The classical headache of brain tumor includes |
|
|
i. a.m._____ | worse |
|
ii. strain cough_____ | increases |
|
iii. bending forward_____ | increases |
|
iv. associated with n_____ and/or v_____ | nausea and/or vomiting |
|
b. Is this constellation truly suggestive of brain tumor? | no |
|
c. What percentage have these “classic” headaches? | 8% (77% had headache similar to tension headache, 9% were similar to migraine, only 8% showed classic brain tumor headache; two thirds of these had high intracranial pressure [ICP]) | |
11. Familial syndromes |
|
|
a. are associated with_____ _____ | CNS tumors | G7 p.588:40mm |
b. which are (Hint: vntLT): |
|
|
i. v_____ _____-_____ | von Hippel-Lindau |
|
ii. n_____ | neurofibromatosis |
|
iii. t_____ _____ | tuberous sclerosis |
|
iv. L_____-_____ | Li-Fraumeni |
|
v. T_____ | Turcot |
|
12. Matching. Match the familial syndromes with the associated CNS tumors. |
| G7 p.588:40mm |
Syndromes: |
|
|
|
|
|
CNS tumors: |
|
|
a. PNET |
| |
b. glioblastoma multiforme (gbm) |
| |
c. hemangioblastoma |
| |
d. subependymal grant cell astrocytoma |
| |
e. vestibular schwannoma |
| |
13. True or False. The following central nervous system (CNS) tumors occur in neurofibromatosis (NF): |
| G7 p.588:108mm |
a. acoustic (vestibular schwannoma) | true (bilateral) |
|
b. meningioma | true |
|
c. ependymoma | true |
|
d. astrocytoma | true (otherwise known as multiple inherited schwannomas, meningiomas, and ependymomas) |
|
e. ganglioglioma | false |
|
14. True or False. The beneficial effect of steroids is greater for |
| G7 p.588:115mm |
a. metastatic tumor | true |
|
b. primary tumor | false |
|
15. What brain tumor has a generally favorable response to chemotherapy? | oligodendroglioma | G7 p.589:90 mm |
16. What tactics can be used to circumvent the blood-brain barrier (BBB)? |
|
|
Hint: lhdb |
|
|
a. l_____ | lipophilic agent nitrosoureas |
|
b. h_____ | higher doses of medications |
|
c. d_____ | disrupt BBB with mannitol |
|
d. b_____ | bypass BBB with intrathecal methotrexate for primary lymphoma |
|
17. What common medication can be used to disrupt the BBB for chemotherapy delivery? | mannitol | |
18. Complete the following about general tumors: |
| G7 p.589:160mm |
a. What is the proper time to obtain postop computed tomographic (CT) scan after brain tumor surgery? |
|
|
i. to check for bleeding use contrast immediately. True or false? | false |
|
ii. to check for residual tumor use contrast_____? | in the first 2 days postop |
|
b. What period of time would be inappropriate to obtain a postop head CT scan with contrast to assess for residual tumor? | during the period 2 days to 8 weeks after surgery is not a reliable testing time for CT or MRI |
|
c. Any exception to this timing rule of thumb? | yes |
|
i. In what case? | pituitary tumors |
|
ii. How long to wait? | 4 months’ delay is recommended |
|
19. Complete the following about general tumors: |
| G7 p.590:45mm |
a. In a pediatric patient with a posterior fossa tumor, what additional test should be done preoperatively? | MRI of lumbosacral spine with contrast |
|
b. Why? | to rule out drop metastases |
|
c. Why not do it postoperatively when you are sure the test is needed? | because postoperative blood may cause an artifact |
|
d. Artifact will last for_____. | 3 weeks |
|
20. Should we place a shunt or external ventricular drain (EVD) into a pediatric patient with a posterior fossa tumor and hydrocephalus? |
| G7 p.590:60mm |
a. pros |
|
|
i. possible lower o_____ m_____ | operative mortality |
|
b. cons |
|
|
i. l_____ shunt | lifelong |
|
ii. s_____ of peritoneum | seeding |
|
iii. u_____ _____ herniation | upward transtentorial |
|
iv. i_____ in shunt | infection |
|
v. d_____ in definitive treatment | delay |
|
Primary Brain Tumors
21. Characterize low-grade gliomas. |
| G7 p.591:58mm |
a. On T1-weighted image (T1WI), they are _____. | hypointense |
|
b. On T2WI, they are_____. | hypointense |
|
c. What percentage enhance? | 30% only |
|
d. A positron emission tomographic (PET) scan may demonstrate_____. | hypometabolism |
|
e. Can they be diagnosed radiologically? | no (Biopsy is needed for definitive diagnosis.) | |
22. Under the WHO classification an astrocytoma with necrosis is called a_____. | GBM | G7 p.594:168 mm |
23. Complete the following about astrocytoma: |
| G7 p.595:50mm |
a. grade I |
|
|
i. frequency_____% | 0.7% |
|
ii. frequency rule of thumb_____% | 1% |
|
iii. median survival_____years | 10 |
|
iv. peak age incidence_____years | 20 |
|
b. grade II |
|
|
i. frequency_____% | 16% |
|
ii. frequency rule of thumb_____% | 15% |
|
iii. median survival_____years | 4 |
|
iv. peak age incidence_____years | 30 |
|
c. grade III |
|
|
i. frequency_____% | 17% |
|
ii. frequency rule of thumb_____% | 15% |
|
iii. median survival_____years | 1.6 |
|
iv. peak age incidence_____years | 40 |
|
d. grade IV |
|
|
i. frequency_____% | 65% |
|
ii. frequency rule of thumb_____% | 65% |
|
iii. median survival_____years | 0.7 (8.5 months) |
|
iv. peak age incidence_____years | 50 |
|
24. Complete the following regarding astrocytoma: |
| G7 p.595:122mm |
a. longevity with low-grade astrocytoma |
|
|
i. aged 45 or younger_____ | ˜5 years |
|
ii. aged 45 or older_____ | ˜1½ years |
|
b. why? |
|
|
i. Because low-grade astrocytomas undergo_____ _____ | malignant transformation |
|
ii. _____-fold more rapidly after | six |
|
iii. age_____ | 45 |
|
25. List astrocytoma GBM microscopic characteristics. |
| G7 p.596:73mm |
Hint: cgppmnn |
|
|
a. c_____ | cellular |
|
b. g_____ a_____ | gemistocytic astrocytes |
|
c. p_____ | pleomorphism |
|
d. p_____ | pseudopallisading |
|
e. m_____ | mitosis |
|
f. n_____ | necrosis |
|
g. n_____ | neovascularization |
|
26. True or False. The following fluid clots: |
| G7 p.596:120mm |
a. cerebrospinal fluid (CSF) | false |
|
b. cyst fluid | true |
|
c. subdural fluid | false |
|
d. blood | true | |
27. Describe astrocytoma CT and MRI characteristics. |
| G7 p.596:165mm |
a. grade I |
|
|
i. CT | low |
|
ii. MRI | abnormal |
|
iii. mass? | no |
|
iv. enhancement? | no |
|
b. grade II |
|
|
i. CT | low |
|
ii. MRI | abnormal |
|
iii. mass? | yes |
|
iv. enhancement? | no |
|
c. grade III |
|
|
i. CT | low |
|
ii. MRI | abnormal |
|
iii. mass? | yes |
|
iv. enhancement? | yes |
|
d. grade IV |
|
|
i. CT | low |
|
ii. MRI | abnormal |
|
iii. mass? | yes |
|
iv. enhancement? | ring |
|
e. In ring enhancement the center represents |
|
|
i. n_____ and the rim is | necrosis | G7 p.597:88mm |
ii. c_____ t_____. | cellular tumor |
|
28. Meningeal gliomatosis occurs in_____% of high-grade gliomas at autopsy. | 20% | G7 p.598:52mm |
29. True or False. Treatments for low-grade gliomas should generally include |
| G7 p.598:145mm |
a. biopsy or surgery for tissue diagnosis | true |
|
b. excisional biopsy | false |
|
c. radiation | false |
|
d. chemotherapy | false |
|
e. excision of pilocytic astrocytomas | true |
|
f. removal because the more tumor removed improves longevity | false (not clearly proven) | G7:p.599:15mm |
30. Complete the following regarding stereotactic biopsy: |
| G7 p.600:20mm |
a. It underestimates the occurrence of GBM by_____%. | 25% |
|
b. Some CNS_____ mimic GBM radiographically. | lymphomas |
|
c. Yield of biopsy is highest when |
|
|
i. low density_____ and | center |
|
ii. enhancing_____ are both sampled. | rim |
|
d. If Karnosky rating is higher than_____ | 70 |
|
e. it portends a_____ prognosis. | better | |
31. Answer the following concerning malignant astrocytoma grade III or IV: |
| G7 p.600:120mm |
a. True or False. Treatment is surgical excision when possible. | true |
|
b. Prognosis from surgical excision and radiotherapy is_____ weeks in the elderly. | 30 |
|
c. Prognosis from biopsy and radiotherapy is_____ weeks in the elderly. | 17 |
|
d. Type of radiotherapy advised is_____. | focal |
|
e. Amount is_____ Gy. | 50 to 60 |
|
32. Characterize wounded glioma syndrome. |
| G7 p.600:175mm |
a. Partial resection of a GBM carries significant risk of_____ | hemorrhage |
|
b. or_____ | edema |
|
c. with resultant_____. | herniation |
|
d. The benefit of subtotal resection is_____. | dubious |
|
e. Surgical excision should be considered if total removal is_____. | feasible |
|
33. Characteristic radiation therapy for |
| G7 p.601:35mm |
a. malignant gliomas is_____ Gy. | 50 to 60 |
|
b. Is whole brain x-ray treatment (XRT) valuable? | no (It does not increase survival.) |
|
34. Considering malignant gliomas, what is the only protocol fully validated by a phase 3 study for treatment of malignant glioma? |
| G7 p.601:125mm |
a. s_____ | surgery—maximal resection |
|
b. r_____, _____ Gy | radiation, 60 Gy |
|
c. c_____ (B_____) | chemotherapy (BCNU at 6-week intervals) |
|
35. Matching. Match level of risk with patient characteristics. |
| G7 p.603:45mm |
Risk: |
|
|
|
|
|
Patient characteristics: |
|
|
a. Age under 40 |
| |
b. Age between 40 and 65 |
| |
c. Frontal tumor |
| |
d. Tumor outside frontal lobe |
| |
e. Karnofsky scale < 80 |
| |
f. Age above 65 |
| |
g. Subtotal resection (STR) |
| |
h. Gross total resection (GTR) | ||
36. What are the common locations of pilocytic astrocytoma? |
| G7 p.603:118mm |
Hint: hoc |
|
|
a. h_____ | hypothalamus |
|
b. o_____ _____ | optic chiasm |
|
c. c_____ | cerebellum |
|
37. Characterize pilocytic astrocytoma. |
| G7 p.604:110mm |
a. Appearance on CT and MRI |
|
|
i. True or False. It enhances. | true (enhancing lesion) |
|
ii. True or False. It is solid. | false (often cystic) |
|
iii. It may have a_____ nodule. | Mural |
|
iv. True or False. It is diffuse. | false (well circumscribed) |
|
b. You should resect the wall of the cyst if the wall_____. | enhances |
|
38. Characterize the radiologic appearance of pilocytic astrocytoma. |
| G7 p.604:110mm |
a. What is their shape? | well circumscribed |
|
b. Do they enhance? | yes—on MRI and CT |
|
c. Are they cystic? | yes |
|
d. Is there anything in the cyst? | mural nodule |
|
e. Are they surrounded by edema? | no |
|
f. Where are they located? | periventricular | G7 p.604:135mm |
39. Complete the following about primary brain tumor: |
| G7 p.605:15mm |
a. cystic cerebellar astrocytoma |
|
|
i. incidence in adults_____% | 10% of CNS tumors |
|
ii. percentage of childhood tumors_____% | 27 to 40% of posterior fossa |
|
b. optic glioma |
| G7 p.606:15mm |
i. incidence in adults_____% | 2% of gliomas |
|
ii. percentage of childhood tumors_____% | 7% of gliomas |
|
c. brain stem gliomas |
| G7 p.607:45mm |
i. incidence in adults_____% | 1% of CNS tumors |
|
ii. percentage of childhood tumors_____% | 10 to 20% of CNS tumors |
|
d. oligodendroglioma |
| G7 p.609:155mm |
i. incidence in adults_____% | 2 to 4% of CNS tumors and 35% of all gliomas |
|
ii. percentage of childhood tumors_____% | small% |
|
e. meningioma |
| G7 p.613:125mm |
i. incidence in adults_____% | 15 to 20% |
|
ii. percentage of childhood tumors_____% | 1.5% of CNS tumors |
|
f. vestibular schwannoma |
| G7 p.620:160mm |
i. incidence in adults_____% | 8 to 10% |
|
ii. percentage of childhood tumors_____% | 0% | |
40. According to Collins’ law, a patient’s tumor is considered cured if |
| G7 p.605:160mm |
a. it does_____ recur | not |
|
b. after a postop period equal to the patient’s_____ | age |
|
c. plus_____. | 9 months |
|
41. Consider treatments for optic glioma. |
| G7 p.606:85mm |
a. One optic nerve involved sparing chiasm, painless proptosis, gliosis of optic nerve head on funduscopy perform_____ and_____ _____. | craniotomy and orbital exploration |
|
i. Treatment should be to e_____ o_____ n_____ | excise optic nerve |
|
ii. from g_____ b_____ | globe back |
|
iii. to c_____. | Chiasm |
|
b. More posterior lesions with nonspecific visual defects, no proptosis, hypothalamic dysfunction, pituitary dysfunction, hydrocephalus, it is likely a _____ _____. | chiasmal lesion |
|
i. Treatment should be b_____ and | biopsy |
|
ii. X_____. | XRT |
|
42. Diencephalic syndrome consists of |
| G7 p.606:135mm |
Hint: diencephalic |
|
|
i. d_____ s_____ | diencephalic syndrome |
|
ii. i_____ a_____ r_____ | intraventricular appearance radiographically |
|
iii. e_____ e_____ | excessively energetic |
|
iv. n_____ | macrocephaly |
|
v. c_____ | cachexia |
|
vi. e_____ | euphoria |
|
vii. p_____ | failure to thrive |
|
viii. h_____ | hypoglycemia |
|
ix. a_____ h_____ | anterior hypothalamus |
|
x. l_____ of s_____ f_____ | loss of subcutaneous fat |
|
xi. i_____ | infiltrating |
|
xii. c_____ u_____ | children usually |
|
43. Characterize brain stem glioma. |
| G7 p.607:28mm |
a. Lower-grade tumors tend to occur in the_____ brain stem. | higher |
|
b. Higher-grade tumors tend to occur in the_____ brain stem. | lower |
|
c. They present with_____ _____ _____ _____. | multiple cranial nerve palsies |
|
d. True or False. Most are surgical candidates. | false |
|
44. How do upper brain stem gliomas present? |
| G7 p.607:65mm |
a. c_____ f_____ | cerebellar findings |
|
b. h_____ | hydrocephalus | |
45. How do lower brain stem gliomas present? |
| G7 p.607:65mm |
a. l_____ c_____ n_____ | lower cranial nerves |
|
b. l_____ t_____ f_____ | long tract findings |
|
46. Characterize four categories of brain stem gliomas. |
| G7 p.607:120mm |
a. diffuse |
|
|
i. location _____, _____, _____ | pons, medulla, cord |
|
ii. glioma grade_____ | malignant |
|
iii. percent_____% | 100% |
|
iv. treatment_____ _____ | no surgery |
|
b. cervicomedullary |
|
|
i. location_____ | cervicomedullary |
|
ii. glioma grade_____ | low |
|
iii. percent_____% | 72% |
|
iv. treatment_____ _____ _____ | surgery if exophitic |
|
c. focal |
|
|
i. location_____ | medulla |
|
ii. glioma grade_____ | low |
|
iii. percent_____% | 66% |
|
iv. treatment_____ _____ _____ | surgery if exophitic |
|
d. exophytic |
|
|
i. location _____, _____ _____ | medulla, spinal cord |
|
ii. glioma grade_____ | low |
|
iii. percent_____% | 60% |
|
iv. treatment_____ _____ _____ | surgery is okay |
|
47. How do brain stem gliomas appear on MRI? |
| G7 p.607:175mm |
a. T1_____ | hypointense |
|
b. T2_____ | increased signal |
|
c. gad_____ | gadolinium highly variable |
|
48. Complete the following about brain stem gliomas: |
| G7 p.608:140mm |
a. Prognosis of most patients is_____ months. | 6 to 12 |
|
b. Subgroup of dorsally exophytic pilocytic astrocytomas have a longer survival of up to_____ years. | 5 | G7 p.608:150mm |
49. Characterize tectal gliomas. |
| G7 p.608:165mm |
a. Pathology is usually_____-_____ _____ that | low-grade astrocytoma |
|
b. presents with_____. | hydrocephalus |
|
c. Diagnostic study of choice is_____. | MRI |
|
d. Symptoms resolve with treatment of the _____. | hydrocephalus | |
e. MRI appearance |
|
|
i. mass arising from the q_____ p_____ | quadrigeminal plate |
|
ii. on T1_____ | isointense |
|
iii. on T2_____ | iso- or hyperintense |
|
iv. gadolinium_____%_____ | 18% enhance |
|
f. Treatment |
|
|
i. s_____ or | shunt |
|
ii. t_____ v_____ | third ventriculostomy |
|
50. Characterize oligodendroglioma. |
| G7 p.609:120mm |
a. Presenting symptom is_____ in_____%. | seizure in 50 to 80% |
|
b. Calcified on |
|
|
i. _____% of skull x-rays | 30 to 60% |
|
ii. _____% of CT scan | 90% |
|
c. Oligodendroglioma cells in a tumor suggests what for the patient? | a better prognosis |
|
51. Characterize oligodendrogliomas. |
| G7 p.609:155mm |
a. They have a predilection for the f_____ l_____. | frontal lobes |
|
b. A classic description of cytoplasm is f_____ e_____. | fried egg |
|
c. The role of chemotherapy is the p_____ t_____ | primary treatment |
|
d. after s_____ r_____. | surgical resection |
|
52. What are the chemotherapy agents used for oligodendrogliomas? |
| G7 p.611:30mm |
Hint: Cvpt |
|
|
a. C_____ | CCNU |
|
b. v_____ | vincristine |
|
c. p_____ | procarbazine |
|
d. t_____ | temozolomide |
|
53. Prognosis: best, middle, worst. Relate. |
| G7 p.611:130mm |
a. Pure oligodendroglioma | best |
|
b. Mixed oligodendroglioma | middle |
|
c. Pure astrocytoma | worst |
|
54. Complete the following regarding prognosis: |
| G7 p.611:130mm |
a. An oligodendroglial component conveys a_____ prognosis. | better |
|
b. Pure oligo 10-year survival is_____%. | 10 to 30% |
|
c. Postop survival is_____ to_____ months. | 35 to 52 |
|
d. Calcification in an oligodendrogliioma (ODG) conveys a_____ prognosis. | better |
|
e. Loss of chromosome 1p conveys a_____ prognosis. | better |
|
f. Loss of chromosome 1p and 19q conveys a_____ prognosis. | better | |
55. Describe central neurocytoma. |
| G7 p.612:105mm |
a. It is located in the l_____ v_____ | lateral ventricles |
|
b. or in the s_____ p_____. | septum pellucidum |
|
c. It tends to affect y_____ a_____ | young adults |
|
d. and is curable by t_____ r_____. | total resection |
|
56. Characterize meningiomas. |
|
|
a. They arise from what cell of origin? | arachnoid cap cell | G7 p.613:90mm |
b. What percentage of meningiomas occur at the falx? (includes parasagittal) | 60 to 70% | G7 p.613:155mm |
c. With foot drop plus hypereflexia, think_____ _____. | parasagittal meningioma | G7 p.614:50mm |
d. Olfactory groove meningiomas |
| G7 p.614:68mm |
i. can produce what syndrome? | Foster Kennedy |
|
ii. consisting of a_____, i_____ o_____ a_____, and c_____ p_____ | anosmia, ipsilateral optic atrophy, and contralateral papilledema |
|
iii. What other syndrome? | frontal lobe |
|
iv. consisting of a_____, i_____ | apathy, incontinence |
|
57. Abulia is |
| G7 p.614:85mm |
a. l_____ o_____ w_____. | lack of willpower |
|
b. characteristic of damage to f_____ l_____. | frontal lobes |
|
c. can occur with a meningioma of the o_____ g_____. | olfactory groove |
|
58. Give a description of asymptomatic meningiomas. |
| G7 p.615:30mm |
a. The most common primary intracranial tumor is_____. | meningioma |
|
b. Percent of primary brain tumors that are meningiomas_____% | 32% |
|
c. Percent that are stable in size over 2½ years_____% | 66% |
|
d. Percent that increase in size when observed for 2½ years_____% | 33% |
|
e. What does calcification tell us about rate of growth? | slower |
|
f. Operative morbidity in patients under 70_____% | 3.5% |
|
g. Above 70_____% | 23% |
|
h. Classic histological finding is the p_____ b_____. | psammoma body |
|
59. Complete the following about MRI and meningioma: |
| G7 p.616:175mm |
a. Meningioma on T1W1 and T2W1 may be _____. | isodense |
|
b. With contrast most will_____. | enhance |
|
c. Accurately predicts sinus involvement in _____%. | 90% |
|
d. A common finding is a d_____ t_____. | dural tail |
|
60. What metastatic cancer can mimic meningioma in the bone on MRI? | prostate | G7 p.617:40 mm |
61. Olfactory groove meningiomas tend to be fed by the |
| G7 p.617:52mm |
a. _____arteries | ethmoidal |
|
b. which are branches of the_____ artery. | ophthalmic |
|
62. The artery of B_____and C_____is enlarged in lesions involving the tentorium (i.e., tentorial meningiomas). | Bernasconi and Cassinari (a branch of the meningohypophyseal trunk) | G7 p.617:65mm |
63. True or False. The artery most likely to be enlarged on an angiogram depicting a tentorial meningioma is the |
| G7 p.617:65mm |
a. superficial temporal artery | false |
|
b. artery of Bernasconi and Cassinari | true |
|
c. occipital artery | false |
|
d. posterior inferior cerebellar artery | false |
|
e. anterior choroidal artery | false |
|
64. Regarding meningiomas and plain x-rays, the plain x-rays may show |
| G7 p.617:110mm |
a. b_____ _____ _____ | blistering of bone |
|
b. c_____ _____ _____ | calcification in tumor 10% |
|
c. d_____ _____—_____ | density changes—hyperostosis |
|
d. e_____ _____ _____ | enlarged vascular grooves |
|
e. f_____ _____ _____ | frontal fossa hyperostosis |
|
65. Complete the following regarding sinus involvement: |
| G7 p.618:20mm |
a. Occlusion of middle third of the SSS is _____. | treacherous |
|
b. Morbidity/mortality is_____/_____%, | 8/3% |
|
c. due to v_____ i_____. | venous infarction |
|
66. Complete the following regarding sinus involvement: |
| G7 p.618:60mm |
a. The sinus may be divided safely anterior to the_____ _____. | coronal suture |
|
b. Posterior to this site the sinus_____ _____ be divided. | must not |
|
c. If tumor is attached, it is best to leave_____ _____. | residual tumor | G7 p.618:82mm |
d. True or False. It is safe to occlude the dominant transverse sinus. | false | G7 p.618:92mm |
67. Complete the following about the removal of meningiomas: |
| G7 p.619:140mm |
a. The Simpson grading system grades the degree of removal of _____. | meningiomas |
|
b. It is important because it correlates with_____ _____. | recurrence rate |
|
c. Components of the system are | In order of complexity, from minimal surgery to complete removal: |
|
i. s_____ r_____,b_____ | small removal, biopsy |
|
ii. p_____ r_____ | partial removal |
|
iii. c_____ r_____ | complete removal |
|
iv. c_____ d_____ | coagulate dura |
|
v. r_____ d_____ and b_____ ands_____ | remove dura and bone and sinus |
|
d. Correlates with grade | ||
i. _____ | V |
|
ii. _____ | IV |
|
iii. _____ | III |
|
iv. _____ | II |
|
v. _____ | I |
|
e. What is the most important factor regarding recurrence? | extent of tumor removal |
|
68. Five year survival for patients with menigioma is _____%. | 91.3% | G7 p.619:150mm |
Vestibular Schwannoma
69. True or False. Vestibular schwannomas (VS) usually arise from which nerve? |
| G7 p.620:145mm |
a. facial nerve | false |
|
b. cochlear nerve | false |
|
c. nervus intermedius | false |
|
d. vestibular nerve, inferior division | false |
|
e. vestibular nerve, superior division | true |
|
70. Vestibular schwannomas arise from the junction of the _____and_____ myelin called the_____-_____zone. | central and peripheral; Obersteiner-Redlich | G6p.429:170mm |
71. Complete the following about primary brain tumors: |
| G6p.429:175mm |
a. What is the Obersteiner-Redlich zone? | site of junction of central and peripheral myelin |
|
b. Where is it located? | 8 to 12 mm from brain stem |
|
c. From what cells do acoustic tumors arise? | from the neurilemmal sheath |
|
d. On what structure do they arise? | the superior division of the vestibular nerve |
|
e. Therefore, are they schwannomas or neuromas? | schwannomas |
|
f. They are the result of a chromosomal defect that leads to |
| |
i. loss of a t_____ s_____gene on the | tumor suppressor on the | G7 p.620:148mm |
ii. l_____ arm of c_____ #_____. | long arm of chromosome 22 |
|
72. True or False. What is the most common chromosomal defect in vestibular schwannomas? |
| G7 p.620:150mm |
a. P53 mutation | false |
|
b. gain of function mutation on Ch 3 | false |
|
c. loss of tumor suppressor gene on Ch 22 | true |
|
d. loss of tumor suppressor gene on Ch 17 | false |
|
e. loss of heterozygosity on Ch 10 | false |
|
73. List the common triad of symptoms seen with vestibular schwannomas. |
| G7 p.621:40 mm |
a. h_____ -_____ % | hearing loss—98% |
|
b. t_____ -_____ % | tinnitus-70% |
|
c. d_____ -_____ % | dysequilibrium-67% (insidious, progressive, 70% have high-frequency loss, word discrimination difficulties) |
|
74. A patient with good hearing has an MRI study that shows a cerebellopontine angle mass. |
| G7 p.621:65mm |
a. Is this compatible with a vestibular schwannoma? | no (At the time of diagnosis virtually all VS have otologic symptoms.) |
|
b. When hearing is involved in VS, what is lost? |
| |
i. low frequencies? | no |
|
ii. high frequencies? | yes (70% have a high-frequency loss pattern.) |
|
iii. word discrimination? | yes (Most have impaired word discrimination, e.g., telephone conversation.) |
|
75. What cranial nerve deficits, other than CN VIII, occur with vestibular schwannomas? |
| G7 p.621:125mm |
a. CN_____;o_____,f_____ n_____,and t_____ c_____ | CN V; otalgia, facial numbness, and taste changes |
|
b. CN_____;f_____ w_____ | CN VII; facial weakness |
|
c. CN_____;h_____ and d_____ | CN IX, X, XII; hoarseness and dysphagia |
|
76. Answer the following about vestibular schwannoma: |
| G7 p.621:135mm |
a. As tumor increases in size the following occur in what sequence? | C, B, A (Facial numbness occurs earlier than facial |
|
A. facial weakness | weakness even though CN V |
|
B. facial numbness | is only slightly compressed, |
|
C. impaired hearing | whereas CN VII is severely distorted early—a paradox. Why? Differential resilience of motor nerves relative to sensory nerves.) |
|
b. What size tumor causes fifth and seventh nerve compression? | larger than 2 cm |
|
77. Complete the following about vestibular schwannomas: |
| G7 p.621:170mm |
a. What percentage of patients have no abnormal physical findings except for hearing loss? | 66% |
|
b. The Weber test lateralizes to the_____ side. | uninvolved (Hearing loss is sensorineural.) |
|
c. Is the Rinne test positive or negative if hearing is preserved? | positive |
|
d. What is normal for the Rinne test? | air conduction > bone conduction = positive means normal. (Note: An A is better than a B.) | |
78. Complete the following about primary brain tumors: |
| G7 p.622:75mm |
a. In VS what causes nystagmus? | vestibular involvement |
|
b. What fibers constitute VS? | ||
i. A_____ _____ n_____ e_____ b_____ f_____ | Antoni A narrow elongated bipolar fibers |
|
ii. A_____ l_____r_____f_____ | Antoni B loose reticulated fibers |
|
c. What is the growth rate for VS? | 1 to 10 mm/year |
|
d. What is the proper follow-up protocol, if no surgery is done? | repeat scan at 6-month intervals for 2 years then once each year |
|
e. Recommend surgery if what occurs? |
| |
i. size changes by_____ | > 2 mm/year |
|
ii. or symptoms_____ | progress |
|
79. Answer the following about the House and Brackmann scale: |
| G7 p.622:15mm |
a. What does the House-Brackmann scale measure? | clinical measurement of facial nerve function |
|
b. What are the categories? | normal mild moderate moderate-severe severe no movement |
|
c. Synkinesis is defined as i_____m_____ accompanying a v_____m_____. | involuntary movement accompanying a voluntary movement |
|
80. Answer the following about vestibular schwannomas: |
| G7 p.625:30mm and G6p.431:110mm |
a. What is the growth rate of vestibular schwannomas? | slow (1 to 10 mm/year) |
|
b. Do some shrink? | yes (6%) |
|
c. Can they remain stable? | yes |
|
d. Can they grow faster? | yes (2 to 3 cm/year) |
|
e. If followed most will show_____ in 3 years. | enlargement |
|
81. Describe the audiometric findings for “useful” hearing in vestibular schwannomas. | 50/50 rule | G7 p.623:90mm |
a. pure-tone audiogram threshold of_____ | ≤50% |
|
b. speech discrimination of_____ | ≥50% |
|
82. Complete the following regarding the Gardener-Robertson system: |
| G7 p.623:108mm |
a. The Gardener-Robertson system is used to grade h_____ p_____. | hearing preservation |
|
b. It consists of |
| |
i. testing patient with_____ _____ of increasing loudness. | pure tones (decibels [db]) (If patient hears dB 0 to 30—excellent hearing; 30 to 50 dB—serviceable; 50 to 90 dB—nonserviceable; 90 dB max—poor; not testable—none) |
|
ii. Evaluating patient ability to understand spoken words is called_____ _____. | speech discrimination (understands words spoken to him or her correct 100 to 70%-excellent; 70 to 50%—serviceable; 50 to 5%— nonserviceable) |
|
c. Useful hearing is judged to be present up to a cutoff point of_____. | 50/50 patient can hear at 50 dB or less and understands at least 50% of words spoken to him or her |
|
83. Name the findings for the following tests in vestibular schwannomas: |
| G7 p.622:175mm |
a. pure-tone audiogram | hearing difference between eachear>10to15dB | |
b. speech discrimination | 4 to 8% score (normal is 92 to100%) | G7 p.623:45mm |
c. brain stem auditory evoked response (BSAER) | prolonged I-III and I-V interpeak latencies | G7 p.624:45mm |
d. electronystagmography (ENG) | abnormal if one ear has ≤35% of total (Normally, 50% of response is from each ear.) | G7 p.624:20mm |
84. Complete the following concerning vestibular schwannoma: |
| G7 p.623:20mm |
a. It causes what kind of hearing loss? | sensorineural loss of high tones |
|
b. This is the same as the loss from | ||
i. _____ | old age |
|
ii. _____ | loud noise exposure |
|
c. Think tumor if the difference between the ears on audiogram is more than_____ dB. | 10to15 |
|
85. True or False. A 55-year-old male is referred for evaluation of a 4.0 cm right cerebellopontine angle (CPA) mass. You conclude it is a vestibular schwannoma. The following is least likely to be a factor in your treatment. Give rationale for each. |
| G7 p.624:65mm |
a. pure-tone audiogram score of 95 dB | false (Audiogram with hearing threshold <50 dB may allow consideration of hearing—sparing procedure, but with a score of 95 dB hearing—saving procedure is not an option.) | G7 p.622:175mm |
b. effacement of the fourth ventricle with modest ventriculomegaly | false (Evidence of hydrocephalus warrants CSF diversion—needs a shunt.) | G7 p.621:170mm |
c. stereotactic surgery 2 years previously | true (Stereotactic radiosurgery 2 years previously is long enough for SRS effect to be over. Surgery should be avoided during the interval 6 to 18 months after SRS because this is the time of maximum damage from the radiation.) |
|
d. contralateral (left) vestibular schwannoma, 1.0 cm in diameter | false (Bilateral VS unable to preserve right hearing [95 dB], will need to plan for second procedure to address the left-sided lesion. Chance of preserving left hearing— 35 to 71% for a 1 cm tumor.) |
|
e. angiogram showing absence of right transverse sinus | false (Atretic/obstructed right transverse sinus allows consideration of translabyrinthine and suboccipital approach as a combined procedure.) |
|
86. True or False. Possible treatments for vestibular schwannomas include |
| G7 p.624:120mm |
a. expectant observation, following symptons, hearing testing, serial, CT, or MRI | true |
|
b. radiation therapy, external beam radiation therapy (EBRT) | true |
|
c. radiation therapy, stereotactic radiosurgery (SRS) | true |
|
d. retrosigmoid (suboccipital) resection | true |
|
e. translabyrinthine resection | true |
|
f. extradural subtemporal (middle fossa approach) resection | true |
|
87. Complete the following about vestibular schwannoma treatment: |
| G7 p.625:115mm |
a. Under 20 mm can be_____, | observed |
|
b. Protocol is to retest at 6,12,18, 24,36, 48,60, 84,108,and 168_____ | months |
|
c. Growth of more than_____ mm between studies deserves treatment. | 2 |
|
d. Tumors larger than 15 to 20 mm should be_____. | treated |
|
e. Tumors with cysts can_____ _____. | grow dramatically | G7 p.625:103mm |
88. Matching. Match outcome with technique with microsurgery and SRS. |
| G7 p.625:170mm |
Outcome:
Technique: | ||
a. microsurgery |
|
|
b. stereotactic radiosurgery |
| |
c. equal |
| |
89. Classically, vestibular schwannomas push the facial nerve in which direction? Pushed_____ and_____ in_____% of cases. | forward and superiorly in 75% | G7 p.627:92mm |
90. Complete the following about vestibular schwannomas: |
| G7 p.627:145mm |
a. Small, laterally located intracanalicular vestibular schwannomas can be removed by what surgical approach? | subtemporal extradural (also known as middle fossa approach) |
|
b. A disadvantage is that the seventh nerve may be_____ at the_____ ganglion. | injured at the geniculate |
|
c. An advantage is that hearing function may be_____. | preserved |
|
91. What is the size vestibular schwannomas should be considered for hearing and CN VII preservation procedures? | < 2 to 2.5 cm | G7 p.627:80mm |
92. What are the advantages of translabyrinthine approach for resecting vestibular schwannomas? |
| G7 p.628:65mm |
a. early identification of the_____ | facial nerve |
|
b. less risk to_____ and_____ _____ _____ | cerebellum and lower cranial nerves |
|
c. best for VS that are located_____ | intracanalicular |
|
93. What are the disadvantages of a translabyrinthine approach for resecting vestibular schwannomas? |
| G7 p.628:65mm |
a. Hearing is_____. | sacrificed |
|
b. Exposure is_____. | limited |
|
c. CSFleakis_____. | more common |
|
94. Complete the following about vestibular schwannomas: |
| G7 p.628:135mm and also G6p.434:122mm |
a. What are the disadvantages of suboccipital approach (also known as retrosigmoid) for vestibular schwannomas? | ||
i. higher_____ when compared with the translabyrinthine approach | morbidity |
|
ii. small tumors_____ | difficult to remove in lateral recess of internal auditory canal (IAC) |
|
iii. facial nerve is located_____ | on blind side deep to the tumor |
|
b. The advantage is the possibility of h_____ p_____. | hearing preservation |
|
95. Complete the following about localizing the VII nerve origin: |
| G7 p.629:145mm |
a. The seventh nerve originates in the_____ sulcus, | pontomedullary |
|
b. anterior to the eighth nerve by_____ mm. | 2 |
|
c. It lies just anterior to the foramen of_____ | Lushka |
|
d. and anterior to a tuft of_____. | choroid |
|
e. It originates _____ mm cephalad to the ninth nerve. | 4 |
|
96. How do you treat postoperative facial nerve weakness after vestibular schwannoma resection? |
| G7 p.630:130mm |
a. N_____T_____ | Natural Tears (2 drops to eye every 2 hours as needed) |
|
b. L_____ | Lacrilube (to eye and tape eye at bedtime) |
|
c. t_____ | tarsorrhaphy within a few days if there is a complete CN VII palsy |
|
d. Anastomose by attaching a portion of the_____ nerve to the_____ nerve | hypoglossal facial |
|
e. When there is no CN VII function and |
| |
i. nerve is known to be divided you may anastomose in_____ | 2 months |
|
ii. nerve is known to be intact you may anastomose in_____ | 1 year |
|
97. True or False. The following symptoms of brain stem compression from a vestibular schwannoma if present postop is not likely to improve: |
| G7 p.630:155mm |
a. nausea | false (Nausea resolves with time.) |
|
b. vomiting | false (Vomiting resolves with time.) |
|
c. balance difficulties | false (Balance difficulties clear rapidly.) |
|
d. ataxia | true (Ataxia from brain stem dysfunction may be permanent.) |
|
98. True or False. The routes of CSF leakage after vestibular schwannoma resection can be via the |
| G7 p.631:20mm |
a. apical cells | true (to tympanic cavities or eustachian tube—most common) |
|
b. vestibule | true (Posterior SCC is usually entered by drilling—via the oral window.) |
|
c. perilabyrinthine cells | true (and tracks to mastoid antrum) |
|
d. mastoid air cells | true (at craniotomy site) |
|
99. True or False. The following is the most likely source of a postoperative CSF fistula after resection of a vestibular schwannoma: |
| G7 p.631:20mm |
a. mastoid air cells via craniotomy site | false |
|
b. through the vestibule of the bony labyrinth via the oval window | false |
|
c. perilabyrinthine cells to the mastoid antrum | false |
|
d. apical cells to the tympanic cavity or eustachian tube | true (All are potential routes but this is the most frequent.) |
|
100. With vestibular schwannoma, postoperative routes for rhinorrhea are |
| G7 p.631:20mm |
Hint: avam |
| |
a. a_____ | apical cells to tympanic cavity and down the eustachian tube |
|
b. v_____ | vestibule after drilling the ICA into the semicircular canal via oval window |
|
c. a_____ | to antrum of mastoid via the perilabyrinthine cells |
|
d. m_____ | mastoid air cells at site of craniotomy |
|
101. What are treatment strategies for CSF leakage after vestibular schwannoma resection? |
| G7 p.631:92mm |
a. What percent stop spontaneously? | 25 to 35% |
|
b. Do what with the head of the bed? | elevate |
|
c. Place a drain where? | lumbar |
|
d. If hydrocephalus is present place a_____. | CSF shunt |
|
e. If leak persists_____. | reexplore surgical site to pack with tissue or apply bone wax |
|
102. What are common complications of vestibular schwannoma surgery? |
| G7 p.631:175mm |
a. CSF leak in_____% | 4 to 27% |
|
b. infection in_____% | 5.7% meningitis |
|
c. stroke in_____% | 0.7% cerebrovascular accident (CVA) |
|
d. CN VII palsy in_____% | 0 to 50% |
|
e. hearing loss in_____% | 34 to 43% |
|
f. death in_____% | 1% |
|
103. Complete the following concerning hearing loss and CN VII weakness after suboccipital removal of VS: |
| G7 p.632:25mm |
a. Tumor < 1 cm |
|
|
i. CN VII preserved,_____% | 95 to 100% |
|
ii. CN VIII preserved,_____% | 57% |
|
b. Tumor 1 to 2 cm |
|
|
i. CN VII preserved,_____% | 80 to 92% |
|
ii. CN VIII preserved,_____% | 33% |
|
c. Tumor > 2 cm |
|
|
i. CN VII preserved,_____% | 50 to 76% |
|
ii. CN VIII preserved,_____% | 6% |
|
104. Complete the following concerning hearing loss after suboccipital removal of VS: |
| G7 p.632:25mm |
a. Hearing preserved_____% with tumors < 1.5 cm | 14 to 48% |
|
b. After SRS hearing preserved_____% with tumors < 3 cm | 26% |
|
105. Concerning acoustic neuroma (i.e., vestibular schwannoma), recurrence following microsurgery is |
| G7 p.633:18mm |
a. _____% after | 10 |
|
b. _____ years follow-up. | 15 |
|
106. Complete the following concerning SRS for vestibular schwannoma: |
| G7 p.633:47mm |
a. Dose recommended is_____. | 14 Gy |
|
b. Local control achieved is_____%. | 94% |
|
107. For vestibular schwannoma, what are local control rates for? |
| G7 p.633:60mm |
a. microsurgery | 97% |
|
b. SRS | 94% |
|
108. When is the time of maximal damage (possible tumor enlargement) from radiation to vestibular schwannomas? |
| G7 p.633:75mm |
a. from_____ to_____ months | 6 to 18 |
|
b. This is important to know because it can produce a false appearance of tumor_____. | enlargement (Surgery should be avoided during the interval of 6 to 18 months after SRS because of damage from radiation and the appearance of tumor enlargement.) | |
109. Most pituitary tumors are benign tumors that arise from the_____ | adenohypophysis | G7 p.634:25mm |
110. Answer the following about pituitary tumors: |
| G7 p.634:37mm |
a. By definition what is the maximal size of a pituitary microadenoma? | 1 cm |
|
b. Larger tumors are called_____ | macroadenomas |
|
c. 50% of pituitary tumors are less than_____ mm. | 5 mm |
|
111. Complete the following about pituitary carcinoma: |
| G7 p.634:48mm |
a. Occurence is_____. | rare |
|
b. They are usually i_____ | invasive |
|
c. They are usually s_____ | secretory |
|
d. The most common hormones are |
|
|
i. a_____ | adrenocorticotropic hormone (ACTH) |
|
ii. P_____ | PRL |
|
e. True or false. They can metastasize. | true |
|
f. Prognosis of 1-year mortality is_____%. | 66% |
|
112. True or False. Regarding pituitary tumors: |
| G7 p.634:67mm |
a. 10% of intracranial tumors | true |
|
b. most common in third to fourth decades | true |
|
c. affect females more often | false (Pituitary tumors affect both sexes equally.) |
|
d. higher incidence in MEN or MEA syndrome | true |
|
e. usually present due to endocrine disturbance or mass effect | true |
|
113. Complete the following about pituitary tumors: |
| G7 p.634:70mm |
a. MEN stands for_____ _____ | multiple endocrine neoplasms |
|
b. MEA stands for_____ _____ | multiple endocrine adenomatosis |
|
c. Incidence of pituitary tumors in MEN is_____. | increased |
|
114. Complete the following about clinical presentation of pituitary tumors: |
| G7 p.634:125mm |
a. Hormone hypersecretion |
|
|
i. _____% of adenomas secrete active hormone | 65% |
|
ii. prolactin_____% | 48% |
|
iii. growth hormone_____% | 10% |
|
iv. ACTH_____% | 6% |
|
v. thyroid-stimulating hormone (TSH)_____% | 1% | |
b. Growth hormone |
|
|
i. If elevated it is due to a_____ _____ | pituitary adenoma |
|
ii. More than_____% of the time. | 95% |
|
c. Corticotropin |
|
|
i. aka_____ | ACTH |
|
ii. Excess causes_____ _____ | Cushing disease |
|
iii. Nelson syndrome can develop only in patients who have had an _____ | adrenalectomy |
|
115. Complete the following about hormone hyposecretion: |
| G7 p.634:180mm |
a. Due to_____ of the normal pituitary | compression |
|
b. In order of sensitivity to compression |
|
|
Hint: go look for the adenoma |
|
|
i. G_____ | GH |
|
ii. L_____ | LH |
|
iii. F_____ | FSH |
|
iv. T_____ | TSH |
|
v. A_____ | ACTH |
|
c. Most common symptom |
| G7 p.635:52mm |
i. o_____ h_____ | orthostatic hypotension |
|
ii. e_____ f_____ | easy fatigability |
|
d. selective loss of one hormone consider_____ | hypophysitis |
|
i. A_____ | ACTH |
|
ii. A_____ | ADH |
|
e. True or False. Diabetes insipidus is seen with preop pituitary tumors. | false |
|
116. Complete the following about mass effect: |
| G7 p.635:95mm |
a. The pituitary tumor that gains the greatest size is |
|
|
i. non-secreting. (True or False) | true |
|
ii. of the secreting type is the_____ | prolactinoma |
|
b. The tumor that is usually the smallest is the_____ tumor. | ACTH |
|
117. Patient presents with sudden onset of headache, visual disturbance, ophthalmoplegia, and reduced mental status. |
| G7 p.635:155mm |
a. Consider diagnosis of p_____ a_____. | pituitary apoplexy (due to expanding mass in sella turcica resulting from hemorrhage or necrosis) |
|
b. This may occur in macroadenomas in as many as_____%. | 3 to 17% | |
118. Complete the following about primary brain tumors: |
| G7 p.636:150mm |
a. What are the indications for rapid decompression after pituitary apoplexy? |
|
|
i. s_____ c_____ | sudden constriction of visual field (VF) |
|
ii. s_____ | severe deterioration of acuity |
|
iii. mental status changes due to h_____ | hydrocephalus (complete tumor removal usually not necessary) |
|
b. What else needs to be done? | treat with corticosteroids |
|
119. Complete the following about the anatomic classification of pituitary adenoma: |
| G7 p.637:15mm |
a. Named the_____ system | Hardy |
|
b. Suprasellar extension |
|
|
i. O | none |
|
ii. A expanding into the_____ cistern | suprasellar |
|
iii. B anterior recesses of third ventricle_____ | obliterated |
|
iv. C_____ of third ventricle_____ | floor; displaced |
|
c. Floor of sella |
|
|
i. Intact or_____ _____ | focally expanded enlarged |
|
ii. Sella_____ | enlarged |
|
d. Sphenoid extension |
|
|
i. Localized_____ of sella floor | perforation |
|
ii. Diffuse_____ of sella floor | destruction |
|
120. Complete the following about functional pituitary tumors: |
| G7 p.637:135mm |
a. What is the most common functional pituitary tumor? | prolactinoma |
|
b. What are its most common symptoms? |
|
|
i. In females,_____-_____ | amenorrhea-galactorrhea |
|
ii. called the syndrome of_____-_____ | Forbes-Albright |
|
iii. causes_____ in males | impotency |
|
c. It arises from anterior pituitary l_____. | lactotrophs |
|
d. The most common cause of amenorrhea is p_____. | pregnancy |
|
121. Answer the following about Cushing syndrome: |
| G7 p.638:25mm |
a. Which hormone? | ACTH |
|
b. It is produced by a_____ tumor. | pituitary |
|
c. It is called Cushing_____. | disease (if tumor is in the pituitary hypercorticalism, it is called Cushing disease) | |
122. Complete the following about pituitary adenoma: |
| G7 p.638:25mm |
a. Adrenocorticotropic hormone (ACTH)— secreting pituitary adenoma is known as_____ _____. | Cushing disease |
|
b. Other causes of hypercortisolism are known as_____ _____ | Cushing syndrome |
|
c. Nelson disease manifests by |
|
|
i. hyper-_____ due to | hyperpigmentation | G7 p.639:30mm |
ii. cross reactivity of m_____ s_____ h_____ with_____.- | melanocyte-stimulating hormone (MSH) with ACTH |
|
123. Complete the following about Nelson syndrome: |
| G7 p.639:30mm |
a. Follows bilateral_____ | adrenalectomy |
|
b. In only_____ to_____% of cases | 10 to 30% |
|
c. Classic triad of |
|
|
i. h_____ | hyperpigmentation |
|
ii. ↑ in_____ | ACTH |
|
iii. Enlargement of the_____ | pituitary tumor |
|
iv. Usually occurs_____ to_____ years after adrenalectomy | 1 to 40 years |
|
d. |
| G7 p.639:90mm |
i. The earliest sign is the_____ _____ | linea negra |
|
ii. Midline pigmentation from the pubis to_____ | umbilicus |
|
iii. And hyperpigmentation of_____ _____ and areolae | scars, gingivae |
|
e. Have an ACTH level greater than_____ Ng/L | 200 | G7 p.639:130mm |
f. The normal being less than_____ Ng/l | 54 |
|
124. Complete the following about pituitary adenoma (Cushing syndrome): |
| G7 p.638:25mm |
a. caused by_____ | hypercortisolism—from any source |
|
b. exogenous source_____ | ingestion of steroids |
|
c. endogenous sources |
|
|
i. p_____ t_____, _____% | pituitary tumor, 60 to 80% |
|
ii. a_____ t_____, _____% | adrenal tumor, 10 to 20%, 15 to 25% |
|
iii. e_____ t_____, _____% | ectopic tumor, 1 to 10%, 5 to 10% |
|
125. Characterize the typical Nelson syndrome scenario. |
| G7 p.639:53mm |
a. patient who had_____ _____ | Cushing syndrome |
|
b. had a surgical procedure_____ | adrenalectomy |
|
c. develops_____ | hyperpigmentation |
|
d. occurs in_____% of such patients | 10 to 30% |
|
e. due to_____-_____of_____ and_____ | cross-reactivity of ACTH and MSH | |
126. To remember Cushing syndrome versus disease: |
| G7 p.638:36mm |
a. syndrome due to_____ | steroids from any source Hint: syndrome = steroids |
|
b. disease due to_____ | pituitary only |
|
127. List the findings in Cushing syndrome. |
| G7 p.638:115mm |
Hint: steroids |
|
|
a. s_____ | striae |
|
b. t_____ | thin skin |
|
c. e_____ | ecchymosis |
|
d. r_____ | reduced libido |
|
e. o_____ | obesity |
|
f. i_____ | impotence, increased blood pressure |
|
g. d_____ | diabetes |
|
h. s_____ | skin hyperpigmentation |
|
128. List the findings in Cushing syndrome. |
| G7 p.639:15mm |
Hint: Ectopic sources of acth secretions |
|
|
Hint: (a) c3 t2 h |
|
|
a. (a) |
|
|
b. c_____ | carcinoma small cell lung |
|
c. c_____ | carcinoid |
|
d. c_____ | (pheo) chromocytoma |
|
e. t_____ | thymoma |
|
f. t_____ | thyroid carcinoma |
|
g. h_____ | islet cell pancreas |
|
129. Characterize pituitary adenoma in Cushing disease. |
| G7 p.638:36mm |
a. secretion of_____ | ACTH |
|
b. most are small <_____ mm | 5 mm |
|
c. only_____% are large enough to produce mass effect | 10% |
|
d. cells produce_____ | proopiomelanocortin (POMC) |
|
e. which contains the precursors for: |
|
|
i. A_____ | ACTH |
|
ii. a_____ | alpha-MSH |
|
iii. b_____ | beta-lipotropin |
|
iv. b_____ | beta-endorphin |
|
v. e_____ | met-enkephalin |
|
130. Criteria for biochemical cure is IGF-1 level less than_____ Ng/mL. | 5 | |
131. Chart. List the effects of excess growth hormone alphabetically. |
| G7 p.640:50mm |
| arthropathy |
|
| acromegaly |
|
| bone |
|
| cartilage |
|
| cardiomyopathy |
|
| diabetes |
|
| entrapment of nerve |
|
| syndromes |
|
| frontal bossing |
|
| fatigue |
|
| glucose intolerance |
|
| gigantism |
|
| hyperhydrosis |
|
| hypertension |
|
| headaches |
|
| infection |
|
| increased hand and foot size |
|
| joint pain |
|
| macroglossia |
|
| malignancies |
|
| neoplasia |
|
| neuropathy |
|
| oily skin |
|
| polyps |
|
| paresthesias |
|
| prognathism |
|
| palmar hyperhydrosis |
|
| respiratory obstruction |
|
| rings no longer fit |
|
| shoe size enlarges |
|
| sleep apnea |
|
| skeletal changes |
|
| soft tissue swelling |
|
| thickened heel pad |
|
| thyromegaly with normal |
|
| thyroid studies |
|
132. Describe the hypothalamic pituitary axis dysfunction in acromegaly. |
| G6 p.441:55mm |
a. Hypothalamus produces_____. | GHRH |
|
b. _____ causes the pituitary to make_____. | GHRH; GH |
|
c. _____ affects the liver, which produces_____ also known as_____. | GH, somatomedin-C, IGF— 1 (hypothalamic GHRH stimulates pituitary GH secretion. Excess GH induces IGF-1 secretion from liver.) |
|
d. What medication can suppress GH release? | somatostatin (Acromegaly findings are due to IGF-1, also known as somatomedin-C.) | |
133. Complete the following about acromegaly growth hormone releasing hormone (GHRH): |
| G6 p.441:56mm |
a. produced in the_____ | hypothalamus |
|
b. causes |
|
|
ii. sy_____ | synthesis of growth hormone |
|
ii. se_____ | secretion |
|
iii. re_____ | release |
|
c. somatomedin-C |
|
|
i. produced in the_____ | liver |
|
ii. due to stimulus of_____ | GH |
|
iii. produces_____ _____ | systemic effects |
|
iv. also known as_____ _____ _____ | insulin-like growth factor (IGF- 1, also known as somatomedin-C) |
|
134. True or False. Regarding acromegaly, somatostatin suppresses growth hormone by interfering with |
| G6 p.441:60mm |
a. synthesis | false |
|
b. secretion | false |
|
c. release of the hormone | true |
|
135. Answer the following about acromegaly: |
| G7 p.640:18mm |
a. Is there any possible ectopic source of growth hormone? | yes |
|
b. If so, what? | carcinoid tumor |
|
136. Answer the following about acromegaly: |
| G7 p.640:135mm |
a. What effect on mortality does elevated GH levels have? Moratality rates are_____ to_____ times normal | 2 to 3 times |
|
b. due to |
|
|
i. c_____ | cancer |
|
ii. c_____ | cardiomyopathy |
|
iii. d_____ | diabetes |
|
iv. h_____ | hypertension |
|
v. i_____ | infection |
|
vi. n_____ _____ | neural entrapment |
|
137. Concerning growth hormone, what effects does GH have on the following? |
| G7 p.640:136mm |
a. mortality rates | ↑ |
|
b. blood pressure | ↑ |
|
c. diabetes | ↑ |
|
d. infections | ↑ |
|
e. cancer | ↑ |
|
f. cardiomyopathy | ↑ |
|
g. closure of epiphyseal plates in children | delays closure |
|
138. Which pituitary tumor is |
| G7 p.638:90mm |
a. least likely to cause mass effect? | ACTH-producing tumor |
|
b. most likely to cause mass effect? | prolactin-producing tumor | |
139. Describe the mass effects of pituitary tumors. |
| G7 p.637:80 mm |
a. What are the structures compressed? |
|
|
Hint: cop |
|
|
i. c_____ s_____ | cavernous sinus |
|
ii. o_____ c_____ | optic chiasm |
|
iii. p_____ | pituitary |
|
b. What are the mass effects usually seen in nonfunctioning pituitary tumors? |
|
|
i. p_____, f_____ p_____, d_____ | ptosis, facial pain, diplopia |
|
ii. b_____ h_____ | bitemporal hemianopsia |
|
iii. h_____ | hypopituitarism |
|
140. Describe the Hardy system of pituitary adenoma classification. |
| G7 p.637:14mm |
a. suprasellar extension of tumor |
|
|
i. _____ | no suprasellar extension |
|
ii. _____ | fills suprasellar cistern |
|
iii. _____ | anterior recess of III ventricle |
|
iv. _____ | displaces floor of III ventricle |
|
v. _____ | intracranial (intradural) |
|
vi. _____ | intracavernous sinus (extradural) |
|
b. invasion |
|
|
i. I s_____ n_____ | sella normal |
|
ii. II s_____ e_____ | sella enlarged |
|
iii. III l_____p_____ of s_____ f_____ | localized perforation of sella floor |
|
iv. IV d_____ d_____ of s_____ f_____ | diffuse destruction of sella floor |
|
v. V s_____via C_____ | spread via CSF |
|
141. What percentage of pituitary adenomas become locally invasive? | 5% | G7 p.637:15mm |
142. Cavernous sinus invasion |
| G7 p.637:60mm |
a. can be suspected if medial wall of sinus is_____ _____. | pushed laterally |
|
b. can be diagnosed if carotid artery is_____. | encased |
|
143. What is the most definite sign of cavernous sinus invasion? | carotid artery encasement | G7 p.637:70mm |
144. Matching. Match the light microscopic appearance of each of the following pituitary tumors with its most common secretory product. |
| G7 p.641:60mm |
Secretory product: |
|
|
|
|
|
Appearance: |
|
|
a. chromophobe |
| |
b. acidophil |
| |
c. basophil | ||
145. What percentage of pituitary tumors are |
| G7 p.641:30mm |
a. endocrine-secretorily active? | 70% |
|
b. endocrine-secretorily inactive? | 30% |
|
146. Complete the following about tumors of the neurohypophysis and infundibulum: |
| G7 p.641:105mm |
a. Most common tumor in the posterior pituitary is_____. | metastasis |
|
b. Most common primary tumor is the_____ _____ _____ | granular cell tumor (GCT) |
|
c. If this tumor is suspected, operative approach is_____. | transcranial |
|
d. MRI appearance is identical to_____ | adenoma |
|
147. True or False. Baseline endocrinologic evaluation of patients presenting with pituitary tumors includes the following among others: |
| G7 p.642:80mm |
a. 8 a.m. cortisol (24 hours is better) | true |
|
b. serum prolactin level | true |
|
c. somatomedin-C | true |
|
d. serum thyroid-stimulating hormone (TSH) | true |
|
e. serum T3 | false |
|
148. List the baseline pituitary function tests. |
| G7 p.642:81mm |
Hint: pqrsTT |
|
|
a. p_____ | prolactin serum level |
|
b. q_____ | Q-cortisol 24 hour |
|
c. r_____ | rest FSH LH FBS (rest means the rest of the endocrine studies) (reproductive) |
|
d. s_____ | somatomedin C |
|
e. T_____ | TSH serum level |
|
f. T_____ | T4 serum level |
|
149. What is the chiasm location in relationship to the sella and the resulting visual field defect? |
| G7 p.642:80mm |
a. prefixed_____% | 5%, homonymous hemianopsia |
|
b. above_____% | 80%, bitemporal hemianopsia |
|
c. postfixed_____% | 5%, ipsilateral loss of vision, junctional scotoma contralaterally, so-called “pie in the sky,” due to compression of the anterior knee of Willebrand | |
150. Visual fields is tested using a small red stimulus because desaturation of color is an early sign of _____ compression. | chiasmal | G7 p.642:170mm |
151. Answer the following about pituitary adenoma: |
| G7 p.643:24mm |
a. What is the classic finding when a tumor compresses the optic chiasm? | bitemporal hemianopsia |
|
b. What occurs in patients with a postfixed chiasm? |
|
|
i. s_____ o_____ q_____ | superior outer (temporal) quadrantanopsia |
|
ii. j_____ s_____ | junctional scotoma |
|
c. due to compression of the k_____ of v_____ W_____ | knee of von Willebrand |
|
d. What occurs in patients with a prefixed chiasm? | homonymous hemianopsia (complete or incomplete) |
|
e. due to compression of _____ or _____ optic tracts | one or both |
|
152. Characterize the pattern of progressive visual field defect caused by pituitary tumor. |
| G7 p.643:24mm |
Fig. 21.1 |
|
|
a. first | superior temporal field |
|
b. second | inferior temporal field |
|
c. third | inferior nasal field |
|
d. fourth | superior nasal field |
|
e. clockwise in the ________ field | right |
|
f. counterclockwise in the ________ field | left | |
153. Describe baseline pituitary evaluation before surgery. (*Note: Results not listed here are also not listed in the Greenberg 6th edition because results vary with age, gender, and menstrual cycle.) |
| G7 p643:70mm |
a. Hint: P8R3st2 |
|
|
i. p_____ | prolactin |
|
normal | < 30 |
|
measured in | ng/mL |
|
maybe abnormal | 25 to 150 |
|
abnormal value | > 150 |
|
ii. (sounds like q) c_____ | cortisol 8 a.m. |
|
normal | 6 to 18 |
|
measured in | μg/100 mL |
|
maybe abnormal | 5 to 10 |
|
abnormal value | > 10 |
|
iii. *(r rest) f_____-s_____ _____ | follicle-stimulating hormone (FSH) |
|
normal |
|
|
measured in |
|
|
maybe abnormal |
|
|
abnormal |
|
|
iv. *(r rest) l_____ | luteinizing hormone |
|
normal |
|
|
measured in |
|
|
maybe abnormal |
|
|
abnormal |
|
|
v. (r rest) f_____ b_____s_____ | fasting blood sugar |
|
normal | 65 to 99 |
|
measured in | mg/dL |
|
maybe abnormal |
|
|
abnormal |
|
|
vi. *s_____ | somatomedin-C |
|
normal | 0.31 to 1.4 |
|
measured in | U/mL |
|
maybe abnormal |
|
|
abnormal |
|
|
vii. *T_____ | TSH | G7 p.445:15mm |
normal | 0.4 to 5.5 mg |
|
measured in | μg |
|
maybe abnormal | peak 2× normal |
|
abnormal | if TSH stimulation test causes peak 2× normal |
|
viii. *T_____ | TH thyroid hormone |
|
normal | 0.8 to 15 |
|
measured in | free T4 index |
|
maybe abnormal |
|
|
abnormal |
| |
b. Also include diagnostic studies of |
|
|
i. f_____ v_____ f_____ | formal visual fields |
|
ii. M_____ w_____ and w_____ e_____ | MRI with and without enhancement |
|
iii. C_____-c_____ v_____ | CT-coronal views (11 tests in all) |
|
154. Thickening of the pituitary stalk and loss of a single pituitary hormone is strongly suggestive of l_____h_____. | lymphocytic hypophysitis | G7 p.643:83mm also see G7 p.1217:55mm |
155. True or False. Regarding lymphocytic hypophysitis: |
| G7 p.643:83mm also see G7 p.1217:55mm |
a. more common in men than women | false (more common in women; only 5 cases reported in men) |
|
b. associated with postpartum state | true |
|
c. affects multiple pituitary hormones | false (affects single hormone) |
|
d. rarely causes diabetes insipidus | false (often causes diabetes insipidus) |
|
156. Characterize screening for Cushing syndrome. |
| G7 p.643:92mm |
a. 8 a.m. cortisol level: normal value is _____ | 6 to 18 μg/100 mL |
|
b. 24-hour urine-free cortisol _____ | more accurate—almost 100% sensitive and specific |
|
157. True or False. Findings of primary hypothyroidism with secondary pituitary hyperplasia include the following: |
| G7 p.645:45mm |
a. prolonged and elevated TSH response to TRH stimulation | true |
|
b. low T4 | true |
|
c. hypoglycemia | false (Hypoglycemia is not part of the syndrome.) |
|
d. elevated TSH | true |
|
e. elevated prolactin | true (Enlarged pituitary causes stalk effect and prolactin increases.) |
|
f. pituitary enlarges because of hypertrophy of the _____ producing cells | thyrotropin releasing hormone (TRH) |
|
g. pituitary enlargement occurs because of the loss of _____ _____ from _____ _____ | negative feedback from thyroid hormones | |
158. Considering pituitary tumors, prolactin is under: |
| G7 p.644:35mm |
a. inhibitory control of the _____ and the infundibular stalk. | hypothalamus |
|
b. Therefore, injury to the hypothalamus or injury to the pituitary stalk causes loss of the inhibitory chemical _____. | prolactin inhibitory factor (PRIF) |
|
c. Does this lead to an increase or decrease in prolactin in the patient? | increase |
|
159. After surgery for prolactin-secreting tumor, what should you think if prolactin is still elevated |
| G7 p.644:33mm |
a. but less than 90 ng/mL _____? | injury to stalk and/or hypothalamus due to loss of prolactin inhibitory factor (PRIF), which is present in the intact stalk and hypothalamus |
|
b. but more than 150 ng/mL _____? | persistent tumor |
|
160. Answer the following about large adenomas with normal prolactin: |
| G7 p.644:160 mm |
a. What should you instruct the laboratory to do? | perform several dilutions and rerun the PRL (This may be a false negative.) |
|
b. This false negative is called the _____ effect. | hook |
|
161. True or False. Extremely high prolactin levels may produce false negatives due to the tendency for large numbers of PRL molecules to prevent formation of PRL-antibody-signal complexes in assays. | true (hook effect) | G7 p.644:160mm |
162. Complete the following about cortisol reserve insulin tolerance test: |
| G7 p.647:115mm |
a. Insulin IV will promptly lower _____ _____. | blood sugar |
|
b. Hypoglycemia is a _____. | stressor |
|
c. In response the body produces _____. | cortisol |
|
d. |
|
|
i. An increment in baseline more than _____ mg/dL | 6 |
|
ii. to a peak of _____ mg/dL is normal. | 20 |
|
e. |
|
|
i. An increment of less than _____ mg/dL | 6 |
|
ii. to a peak less than _____ mg/dL | 16 |
|
iii. indicates a need for g_____ r_____. | glucocorticoid replacement |
|
163. The most useful test for acromegaly is an _____ level. | IGF-1 | |
164. Complete the following about acromegaly and somatomedin-C: |
| G7 p.647:170mm |
a. also known as _____ | IGF-1 |
|
b. normal fasting level _____ | 0.67 U/mL (range 0.31 to 1.4 U/mL) |
|
c. in acromegalics level is _____ | 6.8 U/mL (range 2.6 to 21.7 U/mL) |
|
165. Some growth hormone-secreting pituitary tumors also secrete _____ | prolactin | G7 p.653:20mm also G6 p.447:115mm |
166. Complete the following about growth hormone: |
| G7 p.648:15mm |
a. Normal basal fasting level is _____. | less than 5 ng/mL |
|
b. Acromegalic patients have levels _____ than _____. | greater than 10 ng/mL |
|
c. Due to pulsatile secretion of GH sporadic peaks up to _____ can occur. | 50 ng/mL |
|
d. Is this a reliable test? | no |
|
167. Complete the following about the size of the pituitary gland: |
| G7 p.648:115mm |
a. Size of pituitary gland |
|
|
i. in men up to _____ mm | 10 |
|
ii. in women up to _____ mm child-bearing age up to_____ mm | 9, 11 |
|
iii. in adolescent girls up to _____ mm | 15 |
|
b. size of stalk is same size as b_____ | basilar artery |
|
c. differential diagnosis of large stalk |
|
|
i. l _____ | lymphoma |
|
ii. l_____ h_____ | lymphocytic hypophysitis |
|
iii. g_____ d_____ | granulomatous disease |
|
iv. h_____ g_____ | hypothalamic glioma |
|
168. Findings compatible with pituitary microadenoma on MRI include the following: |
| G7 p.648:145mm |
a. True or False. Lack of early (< 5 minute) gadolinium enhancement | true |
|
b. True or False. Pituitary stalk deviation | true |
|
c. True or False. Thickened pituitary stalk | false (A thickened pituitary stalk is not compatible with adenoma.) |
|
d. True or False. Late (after 30 minute) gadolinium enhancement | true |
|
e. True or False. Timing of scan after gadolinium infusion is important. | true (In early scanning, under 5 minutes, tumor will not enhance but gland will. In late scanning, after 30 minutes, tumor will enhance as well and may not be seen because the gland is also enhanced.) | |
f. The best time to scan for pituitary tumor is _____ minutes after infusion. | 5 |
|
g. At that time what enhances? | normal pituitary tissue |
|
h. Microadenoma is seen since it does _____ _____. | not enhance |
|
169. Characterize the neurohypophysis. |
| G7 p.648:160 mm |
a. normally on T1WI is _____ _____ | high signal |
|
b. possibly because it contains _____ | phospholipids |
|
c. absence of this sign suggests _____ _____ | diabetes insipidus |
|
170. For pituitary tumors, what is the benefit of coronal CT slices? |
| G7 p.649:42mm |
a. sphenoid series _____ | midline (can be identified by the anatomy of sphenoid sinus septa) |
|
b. sella floor _____ | erosion (of the sella floor to indicate presence of the tumor on one side) |
|
171. What is the medical treatment for the following? a. growth hormone-secreting tumors _____ | octreotide | G7 p.653:45mm |
b. ACTH-secreting tumors _____ | ketoconazole | G7 p.654:148mm |
c. prolactin-secreting tumors _____ | bromocriptine | G7 p.651:60mm |
172. Complete the following about nonsecreting pituitary adenomas: |
| G7 p.649:100mm |
a. Usual treatment is with _____ or _____ | S× or XRT |
|
b. |
|
|
i. Medication (bromocriptine) may reduce tumor size by _____% | 20% |
|
ii. Due to the paucity of _____ receptors | dopaminergic |
|
c. Octreotide reduces the tumor by _____% | 10% |
|
d. Follow-up by MRI at: _____, _____, _____, and _____ years | 0.5, 1, 2, and 5 |
|
173. Surgical indications are v_____ f_____ d_____. | visual field defects | G7 p.649:165mm |
174. Tumors secreting GH or ACTH |
| G7 p.650:70mm |
a. warrant _____ treatment | surgical |
|
b. because the secretion is _____ | harmful |
|
c. and there is no effective _____ _____. | medical treatment |
|
175. Complete the following about hormone replacement therapy: |
| G7 p.650:125mm |
a. corticosteroids |
|
|
i. am replacement dose is _____ mg and | 20 |
|
ii. pm replacement dose is _____ mg | 10 | |
b. thyroid hormone |
|
|
i. Do not replace if patient has _____ _____ | adrenal insufficiency |
|
ii. Synthroid _____ μ g/d | 125 |
|
176. Complete the following about primary brain tumors: |
| G7 p.651:24mm |
a. Above what level of prolactin is surgery unlikely to normalize the prolactin? | above 500 ng/mL |
|
b. In such a case what should your treatment be? | medication—dopamine agonists bromocriptine—not surgery |
|
177. Complete the following about prolactinoma as treatment with bromocriptine: |
| G7 p.651:40mm |
a. Response should be evident in _____ to _____ weeks. | 4 to 6 |
|
b. _____% will not respond. | 18% |
|
c. _____% will continue to enlarge on bromocriptine. | 1% |
|
d. Upon discontinuation tumor may _____ _____. | rapidly enlarge |
|
178. What does bromocriptine do? |
| G7 p.651:80 mm |
a. binds to r_____ | receptors |
|
b. inhibits s_____ and s_____ of _____ | synthesis and secretion of PRL |
|
c. lowers prolactin to about _____% of its elevated amount | ˜10% |
|
d. reduces tumor size by _____% in _____ | 75% in 6 to 8 weeks |
|
e. restores _____ | fertility |
|
f. harms patient by _____ | producing fibrosis |
|
g. This reduces good surgical results by _____%. | 50% |
|
h. Therefore, decide about surgery within _____ _____ of starting bromocriptine. | 6 months |
|
i. Prolactinomas may _____ _____ upon discontinuation of the drug. | enlarge rapidly |
|
179. If response to dopamine agonists is satisfactory |
| G7 p.652:90mm |
a. continue to treat for _____ to _____ years and | 1 to 4 |
|
b. check prolactin every _____. | year |
|
c. If tumor not visible on MRI may _____. | discontinue |
|
d. Recurrence rate is highest in the _____ _____. | first year |
|
180. True or False. Surgery is not indicated in elderly asymptomatic patients with GH-secreting pituitary tumors. | true | |
181. Answer the following about pituitary tumors: |
| G7 p.652:130mm |
a. best treatment for prolactinoma PRL < 500 | transsphenoidal surgery |
|
b. best treatment for prolactinoma PRL > | 500 surgery not recommended if PRL > 500 |
|
c. best treatment if prolactin is < 500 try _____ first | medical treatment |
|
d. meds will fail in _____% | 18% |
|
e. treat the failures with _____ | transsphenoidal surgery |
|
f. acromegaly best treatment is _____ | transsphenoidal surgery (Surgery is not recommended for elderly; instead use bromocriptine and/or octreotide.) |
|
g. cure for microadenoma _____% | 85% |
|
h. cure for macroadenoma _____% | 30% |
|
i. Cushing disease best treatment is _____. | transsphenoidal surgery |
|
182. In acromegaly, IGF-1 stabilizes after surgery in _____. | months | G7 p.652:185mm |
183. Complete the following about acromegaly and octreotide: |
| G7 p.652:98mm |
a. suppresses _____ _____ | growth hormone |
|
b. reduces _____, _____% to _____% become _____ | GH in 71%, 50 to 66% become normal |
|
c. reduces _____ in _____%, _____% become _____ | GF-1 in 93%, 66% become normal |
|
d. requires injection _____ | 3 times per day |
|
e. side effects can be _____ | cholelithiasis (10 to 25% of patients) |
|
f. may also be useful in _____ | thyrotropic (TSH)-secreting tumors |
|
184. True or False. Common side effects of octreotide include the following: |
| G7 p.653:120mm |
a. decreased GI motility | true |
|
b. sweating | false |
|
c. diarrhea | true |
|
d. steatorrhea | true |
|
e. bradycardia | true |
|
f. cholelithiasis | true |
|
185. Complete the following about Cushing disease and ketoconazole: |
| G7 p.654:148mm |
a. blocks _____ _____ synthesis | adrenal steroid |
|
b. normalizes _____% of patients | 75% |
|
c. normalizes _____ _____ cortisol | urinary free |
|
d. normalizes _____ steroids | hydroxycortico |
|
e. may cause |
|
|
i. adrenal _____ | insufficiency |
|
ii. hepato-_____ | hepatotoxicity | |
186. True or False. Regarding bilateral total adrenalectomy: |
| G7 p.654:90mm |
a. It is better tolerated than transsphenoidal pituitary surgery. | false |
|
b. Lifelong glucocorticoid replacement is required. | true |
|
c. Lifelong mineralocorticoid replacement is not required. | false | G7 p.654:94mm |
d. Development of Nelson syndrome is rare. | false (Not rare; it occurs in 30%.) |
|
187. Complete the following about thyrotropin-secreting adenomas: |
| G7 p.655:85mm |
a. First-line treatment is _____ _____. | transsphenoidal surgery |
|
b. The tumor may be difficult to remove and _____. | fibrous |
|
c. |
|
|
i. Medical treatment is with the same agent as for _____ | acromegaly |
|
ii. namely, _____. | octreotide |
|
188. Complete the following about pituitary tumors and radiation therapy side effects on: |
| G7 p.655:147mm |
a. cognition |
|
|
i. m_____ d_____ | memory disturbances |
|
ii. l_____ | lethargy |
|
b. vision |
|
|
i. o_____ n_____ and c_____ i_____ | optic nerve and chiasm injury |
|
ii. b_____ | blindness |
|
c. endocrine |
|
|
i. h_____ | hypocorticalism |
|
ii. h_____ | hypothyroidism |
|
d. tumor |
|
|
i. n_____ | necrosis |
|
ii. a_____ | apoplexy |
|
189. Radiation therapy should be routinely used: |
| G7 p.655:160mm |
a. True or False. Following surgical removal of pituitary adenomas | false |
|
b. True or False. If recurrence occurs | false (Repeat surgery is recommended.) |
|
c. Radiation is appropriate in the following circumstances |
| |
i. if recurrence _____ _____ _____ | can’t be removed |
|
ii. if recurrence _____ _____ _____ _____ | mass continues to grow | |
190. Answer the following about radiation for acromegaly: |
| G7 p.656:35mm |
a. True or False. It is the preferred treatment. | false |
|
b. 90% of patients reach normal growth hormone levels in _____ years. | 20 |
|
c. During this time they are exposed to _____ levels of GH | unacceptable |
|
d. and are also exposed to the risks of _____. | radiation |
|
191. True or False. Indications for pituitary surgery include |
| G7 p.649:164mm also G6 p.452:140mm |
a. prolactinomas with levels greater than 500 ng/mL not controlled with surgery | true (Medical treatment will not suffice; both are needed in 18%.) |
|
b. Cushing disease | true (Medical therapy is not adequate.) |
|
c. acromegaly | true |
|
d. macroadenoma | true (if not PRL secreting) |
|
e. visual field defect | true |
|
f. sudden visual loss | true |
|
g. to obtain tissue for diagnosis | true |
|
h. hypopituitarism | false |
|
i. Nelson syndrome | true |
|
192. What is the medical preparation for surgery? |
| G7 p656:90mm |
a. Steroids _____ _____ | stress doses |
|
b. Hypothyroid patients ideally to be treated before surgery for _____ _____ | 4 weeks |
|
193. Regarding pituitary tumors, what artery might you encounter laterally as you open the Hardy speculum and expose the keel of the sphenoid bone? | the sphenopalatine artery—a branch of the maxillary artery, which is the eighth branch of the external carotid artery | G7 p. 656:117mm |
194. Concerning the sublabial approach for pituitary adenoma, what structures can be injured? |
| G7 p.656:118mm |
a. artery g_____ p_____ | greater palatine artery branches (AKA) descending palatal arteries (They enter the incisive foramina and incisive canals.) |
|
b. nerve n_____ | nasopalatine nerves (Branch of maxillary nerve [V2] serves roof of mouth, upper lip, and teeth.) |
|
195. True or False. Regarding pituitary tumors: |
| G7 p.656:150mm |
a. Minimal enlargement of the sella and a large suprasellar mass indicate a transcranial approach. | true | |
b. The subtemporal approach provides good visualization of the optic nerves, chiasm, and carotid arteries. | false (The subfrontal approach is better to see this anatomy.) |
|
c. The subfrontal approach may be more difficult with prefixed chiasm. | true |
|
d. The transsphenoidal approach is preferred for microadenomas. | true |
|
196. Conditions indicating transsphenoidal approach that may not be appropriate for this pituitary tumor include: |
| G7 p.656:151mm |
a. sella not_____ | enlarged |
|
b. large_____ mass | suprasellar |
|
c. e_____ tumor | extrasellar |
|
d. sphenoid_____ | sinusitis |
|
197. Complete the following about transspehenoidal surgery: |
| G7 p.657:185mm |
a. Open the sella exactly in the_____. | midline |
|
b. Use the_____ _____ as your landmark. | nasal septum |
|
c. Is the sphenoid sinus septum also reliable? | no, it is unreliable |
|
198. Complete the following about intraoperative disaster: |
| G7 p.659:100mm |
a. Profuse arterial bleeding suggests_____ _____. | carotid injury |
|
b. It can usually be controlled by_____. | packing |
|
c. |
|
|
i. The operation should_____ _____ | be stopped |
|
ii. and_____ be done. | angiography |
|
d. |
|
|
i. If_____ is found | pseudoaneurysm |
|
ii. the patient is at risk for_____ _____. | lethal rupture |
|
e. |
|
|
i. It must be eliminated by_____ _____ | endovascular techniques |
|
ii. or surgical. | trapping |
|
199. True or False. Common complications of transsphenoidal pituitary surgery include |
| G7 p.659:135mm |
a. transient diabetes insipidus | true (common but lasts less than 3 months) |
|
b. basilar artery injury | false (Basilar artery injury is rare.) |
|
c. cerebrospinal fluid leakage | true (Cerebrospinal fluid leakage is common, 3.5%.) |
|
d. carotid artery rupture | false (Carotid artery rupture is rare.) | |
200. True or False. Treatment for diabetes insipidus includes the following: |
| G7 p.661:125mm |
a. desmopressin 2 to 4 mg daily (subcutaneous) | true |
|
b. vasopressin 5 U (IV) every 6 hours | true |
|
c. desmopressin 10 to 40 mg twice a day | true |
|
d. clofibrate 500 mg four times a day by mouth | true |
|
201. Complete the following regarding postoperative pituitary surgery: |
| G7 p.661:26mm |
a. diabetes insipidus |
|
|
i. can be diagnosed if urine output is more than_____ cc | 250 cc |
|
ii. for_____ | 1 to 2 hours |
|
b. ACTH (corticotropin) reserve |
|
|
i. take patient off steroids for_____ hours | 24 hours |
|
ii. check_____ a.m. cortisol level | 6 a.m. |
|
iii. normal cortisol level at 6 a.m. is_____ | above 9 μg/dL |
|
iv. suspect low cortisol is_____ | 3 to 9 μg/dL |
|
v. definitely low cortisol is_____ | below 3 μg/dL |
|
c. To assess for residual tumor don’t do CT until_____ _____ postoperative. | 4 months | G7 p.661:40mm |
202. Characterize the good outcomes of transsphenoidal surgery. |
| G7 p.662:60mm |
a. vision_____ _____ | much improved |
|
b. prolactin secreting tumors in_____% | 25% |
|
c. growth hormone secreting tumors in_____% | 20% |
|
d. Cushing disease—microadenomas in_____% | 85% |
|
e. acromegaly |
|
|
i. microadenoma in _____% | 85% |
|
ii. macroadenoma in _____% | 30% |
|
iii. all acromegalics in _____% | 50% |
|
f. recurrence _____% | 12% |
|
203. Regarding acromegaly, cure requires: |
| G7 p.662:130mm |
a. basal (morning) serum GH of less than_____ | 5 ng/mL |
|
b. suppression after ingesting glucose less than_____ | 2 ng/mL |
|
c. somatomedin-C (I-GF-1) of normal_____ acromegalics_____ | normal range—0.31 to 1.4 ng/mL; acromegalics 2.6 to 21.7 ng/mL. |
|
204. Characterize biochemical outcome acromegaly. |
| G7 p.662:120mm |
a. Recommended is a_____ serum GH level. | morning |
|
b. Cure is considered GH level of less than ng/ml. | 5 | |
c. In tumors less than 10 mm this is achieved in _____%. | 85% |
|
d. In all acrogmegalics cure is achieved in_____%. | 50% |
|
e. Macroadenomas cure is achieved in_____%. | 30% |
|
f. These patients should be seen for follow-up every_____ to_____ months. | 6 to 12 |
|
205. Answer the following about craniopharyngiomas: |
| G7 p.663:130mm |
a. Craniopharyngiomas are lined with what types of cells? | stratified squamous epithelium |
|
b. They arise from_____ _____ _____ of the pituitary. | anterior superior margin |
|
c. Show calcification |
|
|
i. on histology in _____% | 50% |
|
ii. on plain x-ray in children in_____% | 85% |
|
iii. on plain x-ray in adults in _____% | 40% |
|
d. Do they contain cysts? | yes |
|
e. Do they contain solid components also? | yes |
|
f. Do they undergo malignant degeneration? | no |
|
206. The pituitary stalk can be recognized by its pattern |
| G7 p.664:95mm |
a. of l_____ s_____ | longitudinal striations |
|
b. which are the long_____ _____. | portal veins |
|
207. Describe the Rathke cleft cyst (RCC). |
| G7 p.665:25mm |
a. Where are they located? | intrasellar—pars intermedia |
|
b. How common are they? | incidental finding in 20% of autopsies |
|
c. Do you find RCC together with pituitary adenomas? | no |
|
d. Why? | They arise from the same tissue, which goes one way or the other but not both. |
|
e. appearance on CT |
|
|
i. cystic? | yes |
|
ii. density? | low density |
|
iii. enhancement? | may have capsular enhancement |
|
208. True or False. Rathke cleft cysts arise in/at the: |
| G7 p.665:35mm |
a. anterior superior margin of pituitary | false |
|
b. neurohypophysis | false |
|
c. pars intermedia | true |
|
d. none of the above | false | |
209. Answer the following about Rathke cleft cyst: |
| G7 p.665:35mm |
a. Where is a Rathke cleft cyst located? | in the pars intermedia of pituitary |
|
b. From what does Rathke cleft cyst originate? | remnant of Rathke pouch—stomodeum |
|
210. True or False. A 14-year-old patient is found to have a 3 cm low-density lesion in the sella turcica. Surgical excision reveals a single-layer cuboidal epithelium. The most likely diagnosis is |
| G7 p.665:45mm |
a. mucocele | false |
|
b. epidermoid | false |
|
c. craniopharyngioma | false |
|
d. Rathke cleft cyst | true |
|
211. With a colloid cyst, hydrocephalus involves only the_____ _____. | lateral ventricles | G7 p.665:90mm |
212. Complete the following about primary brain tumors: |
| G7 p.665:120mm |
a. True or False. A 40-year-old male complains of intermittent headaches and gait difficulty. CT scan of head shows a cystic mass in the third ventricle. The most likely diagnosis is |
|
|
i. neurocystercercosis | false |
|
ii. meningioma | false |
|
iii. choroid plexus papilloma | false |
|
iv. colloid cyst | true |
|
b. the site of origin of this cystic mass is the |
|
|
i. d_____ e_____ of the recess of the postvelar arch called | diencephalic ependyma |
|
ii. the p_____ | paraphysis (that is, an evagination of the roof of the third ventricle) |
|
213. True or False. A 27-year-old male with a history of a colloid cyst who underwent a right frontal ventriculoperitoneal shunt 3 days ago returns to the emergency room (ER) with recurrence of severe headaches and gait difficulty. Treatment at this time could be |
| G7 p.110:110mm |
a. removal of ventriculoperitoneal shunt | false |
|
b. externalization of shunt | false |
|
c. placement of left frontal ventricular drainage | true (Colloid cysts can obstruct both foramina of Monro; thus, bilateral ventricular drainage is needed.) |
|
d. medical management and reassurance | false |
|
e. fenestration of the septum pellucidum | true |
|
f. removal of colloid cyst | true | |
214. Complete the following about colloid cyst: |
| G7 p.X:111mm |
a. shunt |
|
|
i. r_____ b_____ s_____ | requires bilateral shunts |
|
ii. or f_____ of s_____ p_____ plus o_____ s_____ | fenestration of septum pellucidum plus one shunt |
|
b. transcallosal approach complications |
|
|
i. v_____ i_____ | venous infarction |
|
ii. f_____ i_____ | fornix injury |
|
c. transcortical approach complications |
|
|
i. s_____ _____% | seizures 5% |
|
d. stereotactic aspiration |
|
|
i. f_____ —r_____ | failure—recurrence |
|
e. ventriculoscopy |
|
|
i. f_____ —r_____ | failure—recurrence |
|
215. Answer the following about hemangioblastoma: |
| G7 p.667:80mm |
a. What is the most common primary intraaxial tumor in the adult posterior fossa? | hemangioblastoma |
|
b. It can occur sporadically or as part of v_____ _____ – _____ disease. | von Hippel-Lindau |
|
c. What blood problem is associated? |
|
|
i. P_____ also known as | polycythemia |
|
ii. e_____ due to | erythropoietin |
|
iii. e_____. | erythropoitin |
|
d. Incidence of brain tumors _____% | 1 to 2% |
|
e. Characteristic appearance c_____ c_____ m_____ w_____ m_____ n_____ | mural nodule |
|
f. Should you remove the cyst wall? | no |
|
216. True or False. A 42-year-old male presents with headache, nausea, vomiting, and right-sided dysmetria. Laboratory studies revealed a hemoglobin of 17. The likely diagnosis is |
| G7 p.667:80mm |
a. metastatic lesion | false |
|
b. renal cell carcinoma | false |
|
c. hemangioblastoma | true (headache, nausea, vomiting-hydrocephalus-dysmetria-cerebellum high hemoglobin-polycythemia) |
|
d. high-grade astrocytoma | false |
|
217. Complete the following about the posterior fossa hemangioblastoma: |
| G7 p.667:80mm |
a. May be associated with |
|
|
i. p_____, e_____ | polycythemia, erythrocytosis |
|
ii. v_____ H_____ -L_____ d_____ | von Hippel-Lindau disease | |
218. Complete the following about von Hippel-Lindau disease (VHL): |
| G7 p.667:130mm |
Has hemangioblastomas tumors or cysts in the following sites: |
|
|
a. c_____ | cerebellum |
|
b. r_____ | retina |
|
c. b_____ | brain stem |
|
d. s_____ | spinal cord |
|
e. p_____ | pheochromocytomas |
|
f. c_____ | cysts in kidneys |
|
219. Complete the following about von Hippel-Lindau disease (VHL): |
| G7 p.667:135mm |
a. Most common in the_____ | cerebellum |
|
b. Second most common in the_____ | retina |
|
c. Always manifests before age_____ | 60 |
|
d. Incidence is 1 in every_____ persons | 35,000 |
|
220. True or False. The mode of inheritance of von Hippel-Lindau disease is: |
| G7 p.667:175mm |
a. autosomal recessive | false |
|
b. autosomal dominant | true |
|
c. sex linked | false |
|
d. multifactorial | false |
|
221. What is the diagnostic criteria for VHL? |
| G7 p.668:60mm |
a. |
|
|
i. One sign of VHL is needed if there is a_____ _____ | family history |
|
ii. It will be present in _____% | 80% |
|
b. Two signs of VHL if it is a_____ _____ mutation | de novo |
|
222. Complete the following about tumors associated with VHL: |
| G7 p.668:105mm |
a. Occur in younger persons if patient has_____ | VHL |
|
b. True or False. Cysts are associated with HGBs. | true |
|
c. Cerebellar HGBs are located in the |
|
|
i. s_____ | superficial |
|
ii. p_____ | posterior |
|
iii. s_____ half of the hemisphere | superior |
|
d. _____% of cerebellar HGBs were found in the_____ | 7%, vermis |
|
223. Complete the following about spinal cord hemangioblastoma: |
| G7 p.668:145mm |
a. _____% are in the cervical and thoracic cord. | 90% |
|
b. _____% are located in the posterior cord. | 96% |
|
c. _____% of spinal HGBs are associated with VHL. | 90% |
|
d. _____% symptoms are associated with syringomyelia. | 95% | |
224. The only disease with bilateral endolymphatic sac tumors is _____. | VHL | G7 p.668:180mm |
225. Complete the following about VHL: |
| G7 p.: mm |
a. Retinal hemangioblastomas occur in_____% | 50% |
|
b. Typically located in the_____ | periphery |
|
c. Frequently_____ | multiple |
|
d. Treat with laser_____ | photocoagulation |
|
226. Complete the following about renal cell carcinoma (RCC): |
| G7 p.669:130mm |
a. Which is the most common malignant tumor in VHL? | RCC |
|
b. Usually it is a_____ _____ _____. | clear cell carcinoma (CCC) |
|
c. It is the cause of death in_____ to_____% of VHL patients. | 15 to 50% |
|
227. Complete the following about surgical treatment of HGB: |
| G7 p.: mm |
a. Reserved until_____ | symptomatic |
|
b. Treatment of choice for_____ _____ HGBs | accessible cystic |
|
c. True or False. The wall must be removed. | false |
|
d. The_____ _____ must be removed. | mural nodule |
|
228. Answer the following about hemangioblastoma (HGB): |
| G7 p.671:17mm |
a. True or False. Starts at an earlier age in |
|
|
i. von Hippel-Lindau disease | true |
|
ii. sporadic cases | false |
|
b. In sporadic cases |
|
|
i. Most originate in the_____ | cerebellum |
|
ii. Next most common is the s_____ c_____ | spinal cord |
|
iii. _____% of patients with cerebellar HGB have VHL | 30% |
|
c. Erythropoitin liberated by the tumor may be responsible for the_____ | erythrocytosis | G7 p.671:53mm |
d. If one HGB is suspected we should do an |
| G7 p.671:140mm |
i. MRI scan of the _____ _____. | entire neuraxis |
|
ii. Vertebral angiography usually demonstrates _____ _____. | intense vascularity |
|
iii. CBC reveals _____. polycythemia |
| |
229. Complete the following about surgery on a solitary HGB: |
| G7 p.672:22mm |
a. It may be_____ in sporadic HGB | curative |
|
b. but not in_____. | VHL |
|
c. Preoperative _____may be helpful. | embolization | |
230. Complete the following about surgery on HGB: |
| G7 p.672:40mm |
a. They should be removed using _____ technique. | AVM |
|
b. Avoid_____ removal. | piecemeal |
|
c. Work along the_____ | margin |
|
d. and_____ the blood supply. | devascularize |
|
CNS Lymphoma
231. Complete the following about CNS lymphoma: |
| G7 p.672:95mm |
a. Associated with an eye condition called_____ | uveitis |
|
b. How frequently does it occur? | 1 to 2% of all brain tumors |
|
c. What relationship does CNS lymphoma have with the ventricles? | up close to ventricles |
|
d. CT characteristics |
|
|
i. plain CT tumor is_____ | hyperdense to brain |
|
ii. contrast CT tumor_____ | enhances homogeneously |
|
iii. reminiscent of_____ _____ _____ | “fluffy cotton balls” |
|
e. reaction to steroids_____ | tumor may completely resolve |
|
f. CSF is positive for lymphoma cells in_____%. | only 10% |
|
g. What form of radiation therapy is given? | whole brain |
|
232. True or False. A 70-year-old male with a homogeneously enhancing lesion in the central gray matter and corpus callosum is suspected of having CNS lymphoma. What would make this diagnosis more likely and how is it properly diagnosed? |
| G7 p.672:107mm |
a. hydrocephalus | false |
|
b. café au lait spots | false |
|
c. uveitis | true (diagnosed with slit lamp) |
|
d. proximal muscle weakness | false |
|
233. A 73-year-old male with a history of recently diagnosed CNS lymphoma by biopsy presents to the ER with stupor and progressively deteriorating mental status. CT of the brain reveals the mass but no other abnormalities. |
| G7 p.675:55mm |
a. True or False. |
|
|
i. emergent surgical excision | false |
|
ii. radiation therapy | true (CNS lymphomas are very sensitive to radiation.) |
|
iii. chemotherapy | false |
|
iv. steroids | false |
|
b. followed by_____ | chemotherapy |
|
Chordoma
234. Complete the following about chordoma: |
| G7 p.675:165mm |
a. It has a characteristic cell type called_____. | physaliphorous |
|
b. It occurs in the clivus in _____%. | 35% |
|
c. It occurs in the sacrococcygeal area in_____%. | 55% |
|
d. The recurrence rate after surgery is_____%. | 85% |
|
e. X-rays show_____ lesions with_____. | lytic lesions with calcifications |
|
f. Is there any gender predominance? | yes, male predominance for sacral chordomas |
|
g. What are the risks to bladder and bowel control |
|
|
i. from a sacrectomy between S1 and S2? | most will be impaired |
|
ii. from a sacrectomy between S2 and S3? | 50% will be impaired |
|
Ganglioglioma
235. True or False. Physaliphorous cells are distinctive features of |
| G7 p.675:165mm |
a. schwannomas | false |
|
b. pinealoblastomas | false |
|
c. gangliogliomas | false |
|
d. chordomas | true |
|
236. Answer the following about gangliogliomas: |
| G7 p.677:165mm |
a. True or False. Peak age of occurrence for gangliogliomas is |
|
|
i. children | true (Peak age is 11.) |
|
ii. elderly | false |
|
iii. no age predilection | false |
|
iv. unknown | false |
|
b. presenting symptom is_____ | seizure |
|
Paraganglioma
237. Complete the following about paraganglioma: |
| G7 p.678:175mm |
a. used to be called_____ | chemodectomas |
|
b. now also called what if at |
|
|
i. carotid bifurcation: c_____ b_____ t_____ | carotid body tumor |
|
ii. jugular foramens: g_____ j_____ | glomusjugulare |
|
iii. adrenal medulla: p_____ | pheochromocytoma | |
c. may secrete |
|
|
i. e_____ | epinephrine |
|
ii. n_____ | norepinephrine |
|
iii. c_____ | catecholamines |
|
d. Resection of carotid body tumor has a |
|
|
i. morbidity of up to _____% | 50% |
|
ii. mortality of _____% | 5 to 13% |
|
238. Complete the following about pheochromocytoma: |
| G7 p.679:80mm |
a. We used to study_____ | catecholamines |
|
b. Better test now is |
|
|
i. f_____ | fractioned |
|
ii. p_____ | plasma |
|
iii. m_____ | metanephrines |
|
c. Imaging is_____ with_____ | MRI; contrast |
|
239. Carotid body tumor |
| G7 p.679:140mm |
a. and_____are the most common paraganglioma. | pheochromocytoma |
|
b. occur bilaterally in _____%. | 5% |
|
240. True or False. A 40-year-old female complains of a painless mass in her right upper neck and has deviation of the tongue to the right. The following is the most likely source of her mass: |
| G7 p.679:160mm |
a. carotid bifurcation | true (Paragangliomas present with mass in neck and CN XI and CN XII nerve palsy.) |
|
b. superior vagal ganglion | false |
|
c. inferior vagal ganglion | false |
|
d. hypoglossal nerve neuroma | false |
|
e. auricular branch of vagus | false |
|
241. Regarding carotid body tumors, treatment carries a_____ complication rate. | high | G7 p.680:25 mm |
242. Complete the following about glomus jugulare tumors: |
| G7 p.680:50mm |
a. They arise from_____ _____. | glomus bodies |
|
b. Are they vascular or avascular? | vascular |
|
c. Receives branches from the_____ _____ _____ | external carotid artery |
|
i. a_____ p_____ | ascending pharyngeal |
|
ii. p_____ a_____ | posterior auricular |
|
iii. o_____ | occipital |
|
iv. i_____ m_____ | internal maxillary |
|
d. _____ portion of the_____ _____ _____ | petrous portion of the internal carotid artery | |
243. Characterize glomus jugulare tumors. |
| G7 p.680:88mm |
a. female to male ratio | 6:1 |
|
b. Does it occur bilaterally? | no |
|
c. presenting symptoms |
|
|
i. h_____ l_____ | hearing loss |
|
ii. p_____ t_____ | pulsatile tinnitus |
|
d. clinical exam abnormalities |
|
|
i. h_____ l_____ and v_____ | hearing loss and vertigo CN VIII |
|
ii. t_____ p_____ t_____ | loss of taste posterior third of tongue CN IX |
|
iii. v_____ c_____ p_____ | vocal cord paralysis CN X |
|
iv. t_____ and SCM w_____ | trapezius and sternocleidomastoid (SCM) CN XI weakness |
|
v. t_____ a_____ and CN _____ i_____ to mass and s_____ of the hearing loss | tongue atrophy CN XII and ipsilateral to mass and side |
|
244. During surgical excision of a paraganglioma the patient is noted to have abrupt onset of hypotension and respiratory distress. This is most likely related to |
| G7 p.680:170mm |
a. intracranial pressure (ICP) changes | no |
|
b. vasovagal response | no |
|
c. inadvertent compression of airway | no |
|
d. tumor manipulation | yes |
|
e. due to r_____ of h_____ or b_____ | release of histamine or bradykinin |
|
245. Describe glomus jugulare differential diagnosis. |
| G7 p.681:15mm |
a. Distinguish from_____ _____ in the CPA | vestibular schwannoma |
|
b. True or False. By CT enhancement | false (Both enhance.) |
|
c. True or False. By presence of cystic component | true (VS may have cystic component.) |
|
d. True or False. By angiography | true (GJ [glomus jugulare] is very vascular.) |
|
e. What else will be learned by angiography? | whether the transverse sinus is occluded |
|
246. Complete the following about glomus jugulare: |
| G7 p.681:120mm |
a. What chemical should be tested for? | vanillylmandelic acid (VMA) |
|
b. If elevated, indicative of secretion of_____ | catecholamines |
|
c. similar to_____ | pheochromocytoma |
|
d. Treat medically_____ with and_____ | alpha and β blockers |
|
e. New clinical marker is_____ (NMN) | normetanephrine | G7 p.679:90mm |
Ependymoma
247. Complete the following about ependymoma: |
| G7 p.682:165mm |
a. Incidence among intracranial tumors in adults is _____%. | 5 to 6% |
|
b. Incidence among pediatric brain tumors is_____%. | 9% |
|
c. It occurs in children _____%. | 70% |
|
d. Incidence among spinal cord gliomas is_____%. | 60% |
|
e. Drop metastases occur in _____% of patients. | 11% |
|
f. What is the pathology of the distinctive type that occurs in the filum terminale? | myxopapillary | G7 p.683:190mm |
248. Characterize intracranial ependymomas. |
| G7 p.683:160mm |
a. usually occur in the_____ _____ | fourth ventricle |
|
b. dangerous to remove because they invade the_____ | floor of the fourth ventricle |
|
c. specifically they invade the_____ | obex |
|
d. current operative mortality _____% | 5 to 8% |
|
e. Is mortality higher in adults or in children? | children |
|
249. Answer the following about postop ependymoma: |
| G7 p.684:123mm |
a. What must we do? | LP |
|
b. When?_____ weeks postop | 2 |
|
c. What should be sent to lab? | 10cc CSF |
|
d. If positive follow with_____ | radiation | G7 p.684:140mm |
e. True or False. Ependymoma is sensitive to radiation. | true |
|
f. Name the tumor that is more sensitive. | medulloblastoma |
|
250. True or False. Regarding primary brain tumors: |
| G6 p.471:180mm |
a. Calcifications, although uncommon in medulloblastomas, may be seen ~20% of the time. | false (< 10%) |
|
b. The “banana sign” in the fourth ventricle refers to the medulloblastoma rather than to ependymomas. | true |
|
c. Ependymomas rank second only to medulloblastomas in radiosensitivity. | true |
|
d. Medulloblastomas arise from the roof of the fourth ventricle, the fastigium. | true |
|
e. Ependymomas arise from the floor of the fourth ventricle, the obex. | true |
|
251. What is the most common glioma of the spinal cord below the midthoracic region? | ependymoma | G7 p.685:100mm |

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

